Introduction {#s1}
============

Gastrulation is the process of coordinated cell fate specification, spatial patterning and morphogenesis that establishes the blueprint of the adult organism. During gastrulation, the pluripotent epiblast (Epi) differentiates into the three definitive germ layers of the embryo; the ectoderm, mesoderm and endoderm. In the mouse, these events are initiated at approximately embryonic day (E) 6.25 by a convergence of signals, emanating from both extraembryonic and embryonic tissues, acting at the proximal, posterior of the embryo. The resulting BMP/Wnt/Nodal/FGF signaling hub drives posterior Epi cells to undergo an epithelial-to-mesenchymal transition (EMT) ([@bib34]; [@bib83]; [@bib5]), establishing a dynamic territory referred to as the primitive streak (PS). The PS elongates and extends distally as gastrulation proceeds. Distinct cell types are specified depending on the time and position at which they undergo EMT and exit the PS ([@bib47]; [@bib52]). Emerging mesenchymal cells either move proximally and laterally, forming the extraembryonic mesoderm, or bilaterally in an anterior direction circumnavigating the space between the Epi and outer visceral endoderm (VE) layers, giving rise to the embryonic mesoderm and definitive endoderm (DE). Epi cells that maintain an epithelial state and do not ingress through the PS form the ectoderm.

Pluripotent stem cells (PSCs) are the in vitro counterpart of the pluripotent Epi of the embryo. They can be expanded indefinitely and differentiated into derivatives of all germ layers ([@bib43]). Standard differentiation protocols generate cell fates in a spatially disorganized manner that is incomparable with in vivo gastrulation. However, it was recently it was shown that, when human embryonic stem cells (hESCs) were differentiated within geometrically uniform, circular micropatterns, they reproducibly patterned cell fates with radial symmetry ([@bib91]; [@bib85]; [@bib26]). Based on a limited number of markers, hESC micropatterned colonies were suggested to give rise to a central ectoderm population followed by concentric circular territories of mesoderm, endoderm, and an outer trophectoderm layer ([@bib91]). These findings revealed the capacity of the BMP, Wnt and Nodal signaling pathways to collectively organize cell fates. The scalability and reproducibility of this assay coupled with the ease of genetically modifying PSCs, the ability to manipulate culture conditions and the simplicity of imaging make this a robust and attractive system to disentangle the cellular behaviors and signaling interactions that pattern mammalian embryos. Even so, this human organotypic system raised many questions, largely due to the absence of a human in vivo standard for direct comparison and assignment of cell identities.

Here we adapted the micropattern-based system to defined medium conditions to precisely dissect signaling requirements, and to mouse PSCs for which in vivo reference points are accessible to assign cell fates. We first converted mouse ESCs to epiblast-like cells (EpiLCs), the in vitro counterpart of the Epi of the early pre-gastrulation embryo ([@bib35]). Mouse EpiLCs seeded onto circular micropatterned surfaces formed a simple epithelial morphology in a flat-disc geometry. By all markers examined, these cells were identical to the Epi of the E5.5-E6.0 embryo. When exposed to gastrulation-promoting factors, micropatterned EpiLCs underwent an EMT and recapitulated organized germ layer differentiation of specific regions of the mouse gastrula. This demonstrated that the cup-shaped geometry of the rodent embryo is not requisite for the spatial patterning of mouse pluripotent cells. Furthermore, the capacity to undergo spatially organized germ layer differentiation under these conditions was specific to EpiLCs. Under the same conditions neither ESCs, corresponding the pre-implantation Epi, nor epiblast stem cells (EpiSCs), corresponding to the gastrulating Epi ([Figure 1A](#fig1){ref-type="fig"}), demonstrated robust cell fate patterning. Hence, the mouse micropattern system offers a defined and quantitative tool to functionally assess the spectrum of described mouse pluripotent states ([@bib59]).

![EpiLCs represent a pluripotent state correlating to the pre-streak epiblast of the embryo.\
(**A**) Development of the mouse pluripotent epiblast (Epi) from embryonic day (E) 4.5 to 7.5 and correlating in vitro pluripotent states. ESCs, embryonic stem cells; EpiLCs, epiblast-like cells; EpiSCs, epiblast stem cells; TE/ExE, trophectoderm/extraembryonic ectoderm; PrE/VE, primitive endoderm/visceral endoderm; DE, definitive endoderm; A, anterior; P, posterior; Pr, proximal; D, distal. (**B**) Sagittal sections of immunostained E5.5-E6.0 embryos. Yellow dashed line demarcates Epi. Scale bars, 25 μm. Non-nuclear anti-BRACHYURY/CDX2/POU3F1 VE fluorescence represents non-specific binding. (**C**) ESCs were converted to EpiLCs on Fibronectin in N2B27 with FGF2 and ACTIVIN A (F/A) and knockout serum replacement (KOSR) for 48 hr. EpiLCs were plated onto Laminin-coated micropatterns overnight and analyzed the following day (0 hr). (**D**) Maximum intensity projections of immunostained 1000 μm diameter EpiLC micropatterned colonies. Scale bars, 100 μm. (**E**) Confocal image showing a z-axis (side profile) region of an immunostained EpiLC micropatterned colony. (**F**) Quantification of immunostaining voxel fluorescence intensity from center (0) to edge (500). Data represents average voxel intensity across multiple colonies. Dashed line represents average fluorescence of Hoechst nuclear stain. n = 6 NANOG/KLF4/SOX2/nuclei; n = 14 GATA6/OTX2/POU3F1; n = 14 BRACHYURY/FOXA2. BRA, BRACHYURY.](elife-32839-fig1){#fig1}

In vivo, we observed a proximal-to-distal gradient of BMP signaling activity -- cells in the posterior (proximal) PS exhibited high signaling activity, while those in the anterior (distal) PS showed no activity. We hypothesized that by modulating the signals provided to mouse PSCs we could recapitulate the proximal-distal environments operative in vivo and generate distinct regional identities in vitro. Exposure of micropatterned EpiLCs to posterior signals, BMP, FGF, ACTIVIN (NODAL) and WNT, promoted an EMT and acquisition of posterior Epi, PS, embryonic and extraembryonic mesoderm identities. When BMP was removed, emulating the anterior PS environment (in which FGF, ACTIVIN and WNT are acting), anterior Epi, anterior PS and/or AxM and DE cell types were formed.

Hence, we demonstrated for the first time that in vitro micropattern differentiation parallels events occurring during gastrulation in vivo in mammalian embryos, and that mouse PSCs residing in a flat-disc geometry can pattern cohorts of neighboring regional identities correlating with those established in the embryo. Utilizing the micropattern system to manipulate the BMP pathway in isolation allowed us to extend findings made in mouse mutants by addressing the anterior versus posterior requirements for this signaling pathway within the PS. We established a direct requirement for BMP4 in posterior mesoderm formation, and demonstrated that BMP signaling is not required for DE and anterior PS/AxM specification. Further quantitative analysis of the signaling dynamics, the role of secreted inhibitors and cell-cell interactions should reveal how pathways operate in a flat-disc-shaped geometry, resembling the majority of mammalian embryos (including human), that can now be directly correlated to mouse, the most developed mammalian genetic model.

Results {#s2}
=======

Micropatterned EpiLCs correspond to the pre-gastrulation epiblast {#s2-1}
-----------------------------------------------------------------

The pluripotent state is a continuum spanning from Epi cell specification in the pre-implantation blastocyst (at approximately E3.5) to differentiation at gastrulation which initiates at E6.25 ([@bib59]) ([Figure 1A](#fig1){ref-type="fig"}). Prior to the onset of gastrulation (E5.5-E6.0), the Epi is in a formative state of pluripotency whereby naïve pre-implantation markers, present in the blastocyst, have been downregulated but differentiation has not yet commenced ([Figure 1B](#fig1){ref-type="fig"}) ([@bib59]; [@bib79]). To establish an in vitro system to model mouse gastrulation, we reasoned that we should start with a PSC population comparable to the in vivo Epi at this time. Global transcriptional profiling identified EpiLCs as the closest in vitro counterpart of the formative Epi ([@bib35]; [@bib79]; [@bib40]; [@bib41]). We sought to determine whether this correlation held when EpiLCs were grown on micropatterned surfaces. EpiLCs were generated as described ([@bib35]) and plated onto 1000 μm diameter micropatterns ([Figure 1C](#fig1){ref-type="fig"}). Fibronectin and Laminin are basement membrane components present at the Epi-VE interface of peri-gastrulation mouse embryos ([@bib90]; [@bib8]). While EpiLCs are generated on a Fibronectin substrate ([@bib35]), we noted superior adhesion of cells to the micropatterns when coating them with Laminin.

Like the pre-streak Epi, micropatterned EpiLCs expressed the pluripotency-associated markers POU5F1 (OCT4), SOX2, NANOG and OTX2, as well as the post-implantation Epi marker, POU3F1 (OCT6) ([Figure 1B,D](#fig1){ref-type="fig"}) ([@bib101]; [@bib2]; [@bib6]; [@bib74]; [@bib33]). Neither the Epi of the pre-gastrula embryo nor EpiLCs expressed KLF4, a key regulator of naïve pluripotency ([Figure 1B,D](#fig1){ref-type="fig"}) ([@bib32]). The pre-streak Epi does not express lineage-associated markers such as GATA6, FOXA2, CDX2 or BRACHYURY and, these were also absent from EpiLC colonies ([Figure 1B,D](#fig1){ref-type="fig"}) except in rare cells that we interpret as having spontaneously differentiated.

Micropatterned EpiLC colonies formed an epithelial monolayer (marked by CDH1, also referred to as E-CADHERIN) ([Figure 1E](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). Cell density within the epithelium increased by nearly a factor of four in 24 hr ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). We noted that micropatterned EpiLCs exhibited a slightly lower cell density than the epithelium of the embryonic Epi at pre- and early gastrulation stages ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). However, in vivo development can also proceed when the Epi cell density is experimentally decreased ([@bib49]).

The uniform size and circular morphology of micropatterned colonies is amenable to the robust quantification of spatial patterning by measuring protein levels as a function of radial position from the colony center to the colony edge ([Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"}) ([@bib91]; [@bib26]). Such quantification indicated that micropatterned EpiLC colonies were spatially homogeneous ([Figure 1F](#fig1){ref-type="fig"}), hence we started with a defined population correlating to the pre-gastrulation Epi at approximately E5.5-E6.0.

EpiLCs exposed to FGF/ACTIVIN/Wnt signaling form a PS-like population {#s2-2}
---------------------------------------------------------------------

At the onset of gastrulation (E6.25-E6.75), the anterior and posterior of the Epi can be distinguished by the expression of specific markers. SOX2 is elevated within the anterior Epi, while NANOG is restricted to the posterior Epi ([Figure 2A--C](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}) ([@bib6]; [@bib33]; [@bib61]; [@bib68]; [@bib20]). The PS emerges in the proximal posterior Epi and is marked by BRACHYURY expression ([Figure 2A--C](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}) ([@bib94]).

![Micropatterned EpiLCs undergo spatially organized differentiation.\
(**A**) Maximum intensity projection (MIP), sagittal and transverse sections of an embryonic day (E) 6.5 mouse embryo. Dashed line marks transverse plane. Non-nuclear anti-BRACHYURY/CDX2/SOX2 VE fluorescence likely represents non-specific binding. ExM, extraembryonic mesoderm; PS, primitive streak; A, anterior; P, posterior; Pr, proximal; D, distal. Scale bars, 50 μm. (**B**) Lookup table (LUT) of SOX2 marking anterior Epi (A-Epi) and NANOG marking posterior Epi (P-Epi). Orange dashed lines delineate regions of interest. (**C**) Quantification (5 sections/embryo/ stage) of SOX2 and NANOG in manually selected (panel B) anterior (A) and posterior (P) Epi of E6.5-E6.75 and E7.0-E7.5 embryos, normalized to Hoechst fluorescence. Data depicts mean fluorescence intensity ± S.D. N, number of embryos. No NANOG was observed in the A-Epi hence \~0.5 a.u. equates to background signal. (**D**) BMP, Wnt, Nodal, FGF signaling initiates gastrulation at the P-Epi - extraembryonic ectoderm (ExE) boundary. BMP4 produced by ExE stimulates *Wnt3* expression within proximal Epi. WNT3 produced by Epi and visceral endoderm (VE) triggers *Nodal* and *Fgf8* expression. NODAL promotes *Bmp4* expression in the ExE. The anterior VE (AVE) expresses Wnt and Nodal pathway antagonists, restricting signaling activity to P-Epi. (**E**) EpiLCs were plated onto Laminin-coated micropatterns overnight (−24 hr) in N2B27 with F/A. The following day medium was changed to F/A, BMP4, WNT3A for 72 hr. Colonies were analyzed at 24 hr intervals. (**F**) MIPs of immunostained 1000 μm diameter colonies. All subsequent data represents 1000 μm diameter colonies. Upper two panels represent a merge of the markers shown below. Second panel shows high magnification of colony edge. Scale bars, 100 μm. BRA, BRACHYURY. (**G**) Depiction of average positional marker expression across multiple colonies. Each dot represents a single cell. (**H**) Quantification of voxel fluorescence intensity from colony center (0) to edge (500). Data represents average voxel intensity relative to maximum voxel intensity across time course/marker. For 0,24,48,72 hr respectively, POU5F1/NANOG n = 5,3,3,3, SOX2 n = 15,7,21,20, BRACHYURY n = 11,9,10,12, GATA6/SOX17/CDX2 n = 3,5,6,5. Markers grouped by spatial distribution within colonies. OTX2 and FOXF1 only analyzed at 72 hr.](elife-32839-fig2){#fig2}

When micropatterned EpiLC colonies were cultured with FGF2 and ACTIVIN A for 72 hr, BRACHYURY was induced at the colony periphery ([Figure 2---figure supplement 1B--D](#fig2s1){ref-type="fig"}), reminiscent of PS formation. In the presence of a small molecule inhibitor of Wnt signaling, XAV939 ([@bib38]), BRACHYURY expression was abolished and SOX2 was homogeneously expressed at high levels ([Figure 2---figure supplement 1B--D](#fig2s1){ref-type="fig"}). BMP inhibition had no obvious effect on BRACHYURY (data not shown). Hence in micropatterned colonies, as in EpiSC cultures ([@bib44]; [@bib50]; [@bib87]; [@bib97]; [@bib82]), BRACHYURY expression was dependent on endogenous Wnt signaling. This suggested that FGF and ACTIVIN support a SOX2-high anterior Epi-like state, while FGF and ACTIVIN combined with endogenous WNT trigger a reduction in SOX2 levels, as in the posterior Epi, and PS gene expression at the colony periphery ([Figure 2---figure supplement 1E](#fig2s1){ref-type="fig"}, [Table 1](#table1){ref-type="table"}). The later germ layer markers GATA6, SOX17 and CDX2 ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}) were not expressed under these conditions indicating that additional factors were required to stimulate further differentiation.

10.7554/eLife.32839.007

###### Summary of cell fates arising in the presence of various signaling factors.

Cell fates generated after 72 hr of mouse micropattern differentiation with described cytokine combinations. It should be noted that cells do not detect these signals homogeneously. WNT inhibition (WNTi) refers to XAV treatment; ACTIVIN inhibition (ACTIVINi) refers to the absence of ACTIVIN and SB431542.

  ---------------------------------------------------------
  Signaling pathways             Outcome
  ------------------------------ --------------------------
  FGF, ACTIVIN, (WNTi)           Epiblast

  FGF, ACTIVIN, endogenous WNT   Epiblast\
                                 PS

  FGF, ACTIVIN, BMP, WNT         Posterior epiblast\
                                 PS\
                                 Extraembryonic mesoderm\
                                 Embryonic mesoderm

  FGF, ACTIVIN, WNT              Anterior epiblast\
                                 Definitive endoderm\
                                 Axial mesoderm or\
                                 Anterior PS

  FGF, BMP, WNT (ACTIVINi)       Epiblast
  ---------------------------------------------------------

Posteriorization of EpiLCs after 24 hr exposure to FGF/ACTIVIN/WNT/BMP {#s2-3}
----------------------------------------------------------------------

In vivo, gastrulation is triggered by a combination of signals from both embryonic Epi cells and the extraembryonic tissues that lie adjacent to the proximal posterior Epi. The extraembryonic signals include WNT3 produced by the VE, and BMP4 produced by the extraembryonic ectoderm (ExE) ([@bib83]; [@bib72]) ([Figure 2D](#fig2){ref-type="fig"}). For the mouse micropattern differentiation we utilized pluripotent EpiLCs, corresponding to the Epi cells of the embryo, and thus the system likely lacked the neighboring extraembryonic cell types and the signals that they provide. We therefore asked whether supplying these signals exogenously could mirror the in vivo signaling environment and initiate gastrulation-like events in vitro.

EpiLCs were plated overnight onto micropatterns in defined serum-free medium containing 12 ng/ml FGF2 and 20 ng/ml ACTIVIN A, supplemented the following day with 50 ng/ml BMP4 and 200 ng/ml WNT3A ([Figure 2E](#fig2){ref-type="fig"}). Under these conditions, EpiLCs underwent robust and reproducible organized germ layer specification ([Figure 2F--H](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2A--C](#fig2s2){ref-type="fig"}).

After 24 hr of differentiation, the EpiLC micropatterned colonies gave rise to two populations -- a central population expressing the Epi markers POU5F1, SOX2 and NANOG, and an outer population expressing the PS marker BRACHYURY ([Figure 2F,G](#fig2){ref-type="fig"}). From 0 to 24 hr, SOX2 levels were reduced approximately 2-fold within the central population ([Figure 2F--H](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2D](#fig2s2){ref-type="fig"}). Conversely, there was no change in NANOG expression ([Figure 2H](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2D](#fig2s2){ref-type="fig"}). Hence, a NANOG-positive, SOX2-low state emerged as is present in the posterior Epi of the embryo ([@bib36]) ([Figure 2A--C](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2D](#fig2s2){ref-type="fig"}). Concomitantly, BRACHYURY was induced at the colony edge ([Figure 2F--H](#fig2){ref-type="fig"}). BRACHYURY and SOX2 expression was predominantly mutually exclusive but showed a degree of overlap ([Figure 2---figure supplement 2E](#fig2s2){ref-type="fig"}), which was also observed in cells within the PS in vivo ([Figure 2A](#fig2){ref-type="fig"}) and may mark an Epi-PS transition state. At this time, no later germ layer-associated markers (GATA6, SOX17, CDX2, FOXA2) were expressed ([Figure 2F,H](#fig2){ref-type="fig"}). Hence, the first 24 hr of micropattern differentiation with exogenous BMP and WNT generated populations resembling the posterior Epi and emerging PS of the mouse embryo at approximately E6.25-E6.75, as observed in the presence of FGF, ACTIVIN and endogenous WNT ([Figure 2---figure supplement 1B--D](#fig2s1){ref-type="fig"}).

Identification of marker signatures to track germ layer differentiation {#s2-4}
-----------------------------------------------------------------------

As gastrulation proceeds, an increasingly complex array of populations are specified -- the anterior and posterior Epi, the PS, the embryonic and extraembryonic mesoderm (arising from the posterior PS) and the DE and AxM (arising from the anterior PS) ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). To identify these cell states in vitro in the absence of the spatial and temporal context of the embryo, we sought to establish marker signatures of the cell types present in gastrula stage embryos. To do this, we performed immunostaining for a panel of factors on gastrulating wild-type mouse embryos, and supplemented our observations with published data ([Supplementary file 1](#supp1){ref-type="supplementary-material"} and [2](#supp2){ref-type="supplementary-material"}).

At E6.5-E7.5, the anterior Epi expresses high levels of SOX2 and OTX2 while the posterior Epi expresses low levels of SOX2 and high levels of NANOG ([Figure 2A--C](#fig2){ref-type="fig"}, [Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}). In agreement with a recent spatial transcriptional analysis of gastrulating mouse embryos ([@bib69]), our immunostaining data suggested that posterior Epi cells may also express low levels of OTX2 ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}). At E7.0-E7.5, a fraction of distal posterior Epi cells begin to express FOXA2 ([Figure 3A](#fig3){ref-type="fig"}) ([@bib13]), some of which also express OTX2 ([@bib69]; [@bib25]).Then, by E7.75, CDX2 is expressed throughout the posterior Epi ([Figure 3B](#fig3){ref-type="fig"}) ([@bib19]). By E7.75-E8.0, SOX2 continues to be expressed at high levels in the anterior neurectoderm and at low levels in the posterior, while NANOG is no longer observed within the Epi (see [Supplementary file 2](#supp2){ref-type="supplementary-material"}) ([@bib68]).

![Assignment of cell identities to micropattern-differentiated EpiLC populations.\
(**A,B,D**) Confocal maximum intensity projections (MIP), sagittal optical sections and transverse cryosections of immunostained gastrulating embryos. Dashed lines mark transverse plane. Epi, epiblast; PS, primitive streak; M1, Mesoderm1; M2, Mesoderm2; ACD, allantois core domain; AOM, allantois outer mesenchyme; ExE, extraembryonic ectoderm; Al, allantois; ExM, extraembryonic mesoderm; A, anterior; P, posterior; Pr, proximal; D, distal; R, right; L, left. Scale bars, 50 μm. (**A**) Yellow arrowheads mark BRACHYURY/FOXA2-coexpressing cells within the anterior PS. (**C**) LUT of immunostaining of BRACHYURY marking extraembryonic mesoderm allantois core domain (ACD) and CDX2 expressed highly in allantois outer mesenchyme (AOM) (upper panels) as well as GATA6 marking anteriorly migrated embryonic mesoderm (Mesoderm 1) and BRACHYURY marking embryonic mesoderm close to the PS (Mesoderm 2) (lower panels). Orange dashed lines delineate regions of interest. (**E,F,H**) MIPs of immunostained micropatterns. High magnification shows region at the colony edge. Yellow arrowhead H marks GATA6/FOXF1 cell. Scale bars, 100 μm. (**G**) High magnification of colony edge. Outer domain represents a mixture of populations often organized in clusters, highlighted by dashed lines. At 48 hr the ACD population coexpressed BRACHYURY and CDX2, M1 expressed GATA6. By 72 hr, outer cells expressed CDX2 (AOM) or GATA6 (M1). BRACHYURY marked PS cells. (**I**) Schematic diagram summarizing the cell identities observed at 48 and 72 hr of in vitro differentiation, under conditions described in B and corresponding in vivo fates. Dashed lines mark transverse plane. ExM, extraembryonic mesoderm.](elife-32839-fig3){#fig3}

Throughout gastrulation, BRACHYURY is expressed by cells within the PS ([Figures 2A](#fig2){ref-type="fig"} and [3A,B](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1C,F](#fig3s1){ref-type="fig"}). The first cells to leave the posterior Epi and exit the PS at E6.5-E6.75 coexpress BRACHYURY and GATA6 ([Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}). Over time, these cells adopt distinct mesodermal and DE identities. Cells that exit the posterior PS and move proximally into the extraembryonic region generate the extraembryonic mesoderm. The extraembryonic mesoderm forms structures involved in the exchange of materials between the embryo and the mother, including the allantois and yolk sac. Additionally, the extraembryonic mesoderm is a source of hematopoietic progenitors and factors associated with early hematopoiesis, such as *Sox17* and *Hhex*, are expressed within the allantois ([@bib86]; [@bib7]; [@bib77]; [@bib12]). At E7.75-E8.0, the extraembryonic mesoderm can be subdivided into the allantois core domain (ACD) - expressing BRACHYURY, SOX17, CDX2, FOXF1, the allantois outer mesenchyme (AOM) - expressing SOX17, CDX2, GATA6, FOXF1 and the yolk sac mesoderm (YSM) - expressing GATA6 and FOXF1 ([Figure 3C,D](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1D](#fig3s1){ref-type="fig"}) ([@bib19]; [@bib12]; [@bib30]; [@bib15]; [@bib70]; [@bib29]). The allantois is reported to express *Gata6* at this time ([@bib62]), although at the protein level GATA6 was not evident until slightly later stages. At E8.5, CDX2, SOX17 and GATA6 are expressed throughout the allantois ([Supplementary file 2](#supp2){ref-type="supplementary-material"}). Over time, cells of the ACD contribute to the AOM to support allantois elongation ([@bib23]).

Cells that originate from the posterior PS and move in an anterior direction around the embryo will form the embryonic mesoderm. At E7.5-E8.0, based on protein expression, we could distinguish two populations of embryonic mesoderm, which we refer to here as Mesoderm 1 and Mesoderm 2 ([Figure 3C](#fig3){ref-type="fig"}). Mesoderm 1 cells, which exited the PS earlier and were located more anteriorly, expressed GATA6 and OTX2 ([Figure 3B--D](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}) ([@bib30]; [@bib62]). Mesoderm 2 cells, which left the PS later and so were more posterior, expressed BRACHYURY and FOXF1 ([Figure 3B--D](#fig3){ref-type="fig"}) ([@bib70]). To note, GATA6 and FOXF1 showed a degree of overlap within the region between Mesoderm 1 and 2 ([Figure 3D](#fig3){ref-type="fig"}).

Over time, the PS extends distally within the cup-shaped mouse embryo and cells that emanate from the anterior PS give rise to the DE and AxM. Although BRACHYURY is expressed along the length of the PS, at the anterior PS a fraction of cells coexpress BRACHYURY and FOXA2 while others express only FOXA2 ([Figure 3A](#fig3){ref-type="fig"}) ([@bib13]). Both DE and AxM cells express FOXA2, OTX2, *Gsc* and *Hhex*, although *Gsc* and *Hhex* may be present only transiently within the AxM ([Figure 3A](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1E](#fig3s1){ref-type="fig"}) ([@bib86]; [@bib98]; [@bib73]; [@bib10]; [@bib78]). Additionally, DE cells express SOX17 ([Figure 3---figure supplement 1E](#fig3s1){ref-type="fig"}) and GATA6 ([@bib90]; [@bib30]). AxM cells also express BRACHYURY ([Figure 3---figure supplement 1F](#fig3s1){ref-type="fig"}) ([@bib94]).

Utilizing these in vivo marker signatures ([Supplementary file 1](#supp1){ref-type="supplementary-material"}), we sought to assign identities to the cell populations arising at 48--72 hr of micropattern differentiation, and consequently map the in vitro differentiation to in vivo development.

FGF/ACTIVIN/WNT/BMP triggers spatially organized posterior fate specification {#s2-5}
-----------------------------------------------------------------------------

The first 24 hr of micropattern differentiation in the presence of FGF, ACTIVIN, BMP and WNT resulted in EpiLC posteriorization and the emergence of a PS-like population ([Figure 2F,G](#fig2){ref-type="fig"}). At 48 and 72 hr of micropattern differentiation, further spatially organized germ layer differentiation was observed. Three colony domains (central, mid and outer concentric circles) were evident based on marker expression ([Figure 2---figure supplement 2A--C](#fig2s2){ref-type="fig"}) and the populations within these domains were largely conserved between time points.

At both 48 and 72 hr, the colony center continued to express NANOG and low levels of POU5F1 and SOX2 as in the posterior Epi ([Figure 2F--H](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2D](#fig2s2){ref-type="fig"}). Additionally, at 72 hr, OTX2 and FOXA2 were observed within the colony center ([Figure 3E](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1G](#fig3s1){ref-type="fig"}) analogous to the expression of these markers within the mid to distal region of the posterior Epi at E7.0-E7.5 ([Figure 3A](#fig3){ref-type="fig"}) ([@bib25]). While OTX2 and SOX2 are also highly expressed within the in vivo anterior Epi ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}), the additional expression of the posterior-restricted marker NANOG, as well as FOXA2, within the colony center ([Figure 2A](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2D](#fig2s2){ref-type="fig"}, [Figure 3A,E](#fig3){ref-type="fig"}) suggested that these cells were more similar to posterior than anterior Epi. In vivo, CDX2 expression is induced within the posterior Epi at E7.5-E7.75 ([Figure 3B](#fig3){ref-type="fig"}) but was not observed within the center of micropatterned colonies ([Figures 2F](#fig2){ref-type="fig"} and [3F](#fig3){ref-type="fig"}). Therefore, based on the expression of FOXA2 but not CDX2, the central population likely correlated to the posterior Epi later than E7.0, but prior to E7.75.

At 24 hr, BRACHYURY marked a PS-like population at the colony periphery ([Figure 2F--H](#fig2){ref-type="fig"}). However, at 48 and 72 hr BRACHYURY-positive cells were observed more centrally, within the mid micropattern domain ([Figure 2F--H](#fig2){ref-type="fig"}). This inwards shift of BRACHYURY suggested either a wave of gene expression propagating throughout the colony or an inward movement of BRACHYURY-expressing cells. In vivo, BRACHYURY is expressed by cells within the PS, but is additionally present in the first cells emanating from the PS -- where it is coexpressed with GATA6, and in the extraembryonic mesoderm ACD -- where it is coexpressed with CDX2 and SOX17. While we observed cells that coexpressed BRACHYURY and GATA6 or CDX2/SOX17 (discussed later), the majority of BRACHYURY-positive cells did not express these markers, and hence likely corresponded to PS ([Figure 3---figure supplement 1H,I](#fig3s1){ref-type="fig"}).

The outermost micropattern domain comprised several distinct cell populations with expression signatures reminiscent of embryonic and extraembryonic mesoderm. A small fraction of cells coexpressed GATA6 and BRACHYURY, as in the first cells leaving the PS ([Figure 3---figure supplement 1C,J,K](#fig3s1){ref-type="fig"}). Additionally, we observed cells that coexpressed GATA6 and OTX2, as in Mesoderm 1 ([Figure 3B](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1B,G](#fig3s1){ref-type="fig"}). While in vivo we could also discern a second population of embryonic mesoderm (Mesoderm 2) that expressed FOXF1 and BRACHYURY ([Figure 3B--D](#fig3){ref-type="fig"}), within the micropatterned colonies FOXF1 was restricted to the colony periphery in a spatially distinct domain from BRACHYURY ([Figures 2H](#fig2){ref-type="fig"} and [3H](#fig3){ref-type="fig"}). Hence Mesoderm 2 was likely not generated under these in vitro differentiation conditions.

Within the same outer colony domain, we identified populations resembling extraembryonic mesoderm cell types. CDX2 was expressed within the outer domain from 48 hr of differentiation ([Figures 2F--H](#fig2){ref-type="fig"} and [3F](#fig3){ref-type="fig"}). At this time, almost all CDX2-positive cells coexpressed BRACHYURY and SOX17 ([Figures 2F](#fig2){ref-type="fig"} and [3F,G](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). In vivo, coexpression of BRACHYURY, SOX17 and CDX2 is first observed within extraembryonic mesoderm cells of the ACD ([Figure 3---figure supplement 1D](#fig3s1){ref-type="fig"}). While BRACHYURY, SOX17 and CDX2 are also all expressed within cells of the hindgut at later stages of development (E8.5) ([@bib53]), this micropattern population did not express additional hindgut markers such as FOXA2 ([@bib58]; [@bib3]; [@bib75]) ([Figure 3E](#fig3){ref-type="fig"}). Hence BRACHYURY/SOX17/CDX2-positive cells correlated most strongly to the extraembryonic mesoderm ACD.

At 72 hr, the BRACHYURY/SOX17/CDX2 population was no longer observed. CDX2 and SOX17 continued to be coexpressed ([Figure 3F,G](#fig3){ref-type="fig"}) but these cells now lacked BRACHYURY expression ([Figures 2F](#fig2){ref-type="fig"} and [3F,G](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1J](#fig3s1){ref-type="fig"}). At 72 hr, CDX2-positive cells also expressed FOXF1, another marker found within the extraembryonic mesoderm ([Figure 3D](#fig3){ref-type="fig"}). Hence, SOX17/CDX2/FOXF1-positive cells likely corresponded to the AOM, suggesting a temporal progression of ACD cells to an AOM state, as in vivo. We also observed a rarer population of cells that coexpressed FOXF1 and GATA6 ([Figure 3H](#fig3){ref-type="fig"}, yellow arrowhead) as in the YSM or embryonic mesoderm positioned between Mesoderm 1 and 2 ([Figure 3D](#fig3){ref-type="fig"}). While both embryonic (GATA6) and extraembryonic (SOX17/CDX2/FOXF1) mesoderm-like populations were present within the outer micropattern domain, they tended to exist within discrete clusters ([Figure 3G](#fig3){ref-type="fig"}).

During the micropattern differentiation, multiple DE-associated markers were expressed, namely FOXA2, SOX17, GATA6 and OTX2. In vivo these markers are coexpressed within DE cells ([Figure 3---figure supplement 1E](#fig3s1){ref-type="fig"}) while in the micropattern differentiation FOXA2, SOX17 and GATA6 were expressed in a mostly mutually exclusive manner ([Figure 3E](#fig3){ref-type="fig"}, [Figure 3---figure supplement 2A](#fig3s2){ref-type="fig"}), hence they marked separate non-DE populations. Furthermore, BRACHYURY and FOXA2 were expressed within distinct micropattern domains (mid and central respectively) ([Figures 2F,G](#fig2){ref-type="fig"} and [3E](#fig3){ref-type="fig"}) suggesting that AxM cells were not present. To further validate these conclusions, we assessed the expression of the DE and AxM markers *Gsc* and *Hhex* using a *Gsc^GFP/+^; Hhex^RedStar/+^* dual reporter ESC line ([@bib89]). After 72 hr of differentiation, *Hhex^RedStar^* was observed at the outer colony edge but *Gsc^GFP^* was not expressed ([Figure 3---figure supplement 2B](#fig3s2){ref-type="fig"}). The expression of *Hhex^RedStar^* and SOX17, without FOXA2 and *Gsc^GFP^* expression, confirmed the absence of DE and AxM fates and likely indicated the presence of hematopoietic progenitors that arise from the allantois ([@bib86]; [@bib18]) and

Therefore, in vitro, a combination of BMP, WNT, ACTIVIN (NODAL), and FGF promoted the specification and spatial organization of posterior Epi (center), PS (mid) and embryonic and extraembryonic mesoderm (outer), recapitulating gastrulation events occurring within the posterior of the mouse gastrula ([Figure 3I](#fig3){ref-type="fig"}, [Table 1](#table1){ref-type="table"}). However, fates arising from the anterior PS including DE and AxM were not formed under these conditions.

Micropattern differentiation involves a TGFβ-regulated EMT {#s2-6}
----------------------------------------------------------

One of the primary hallmarks of gastrulation is an EMT, involving downregulation of the epithelial marker CDH1 (E-CADHERIN) and upregulation of the mesenchymal marker CDH2 (N-CADHERIN) in cells ingressing through the PS ([Figure 4A,B](#fig4){ref-type="fig"}). Epi cells that do not undergo an EMT differentiate into neurectoderm, while those that undergo an EMT emanate from the PS and acquire mesoderm or DE identities ([@bib5]; [@bib28]). We asked whether micropattern differentiation engaged these same morphogenetic processes.

![EMT is associated with micropatterned EpiLC differentiation.\
Data from colonies differentiated as in [Figure 2E](#fig2){ref-type="fig"}. (**A,B**) Sagittal (**A**) and transverse sections (**B**) of late streak embryo. Dashed box marks high magnification region in lower panel. Dashed lines mark transverse planes in B. Non-nuclear anti-BRACHYURY VE fluorescence represents non-specific binding. A, anterior; P, posterior; Pr, proximal; D, distal; L, left; R, right; VE/DE, visceral endoderm/definitive endoderm; ExE, extraembryonic ectoderm; ExM, extraembryonic mesoderm; Epi, epiblast; Meso, mesoderm. Scale bars, 50 μm. (**C**) Quantification of colony height from colony center (0) to edge (500) across multiple colonies, three independent experiments, 0 hr: n = 11, 24 hr: n = 15, 48 hr: n = 17, 72 hr: n = 18. (**D**) Time-course showing brightfield images (upper panels) and MIPs of comparable immunostained colonies (lower panels). Scale bars, 100 μm. (**E--G**) Images of z-axis profile from colony center (left) to edge (right). (**G--I**) EpiLCs were plated onto micropatterns overnight with F/A. The following day medium was changed to F/A, BMP4, WNT3A (**E,F**) or medium blocking Activin/Nodal signaling - FGF2, BMP4, WNT3A, SB431542 (ACTIVINi, (**G--I**). (**H**) brightfield image of ACTIVINi colony. (**I**) MIPs of immunostained ACTIVINi colonies at 72 hr differentiation. Scale bars, 100 μm. BRA, BRACHYURY.](elife-32839-fig4){#fig4}

A PS-like population arose after 24 hr of in vitro differentiation ([Figure 2F](#fig2){ref-type="fig"}) followed by the formation of a 2--3 cell layer ridge at the colony perimeter at 48 hr ([Figure 4C,D](#fig4){ref-type="fig"}). By 72 hr, the ridge was positioned more centrally, suggesting an inwards movement, resulting in a volcano-like structure ([Figure 4C,D](#fig4){ref-type="fig"}). Initially, the ridge overlapped with the BRACHYURY/CDX2 coexpression domain but, at 72 hr, was positioned at the border between the BRACHYURY-positive PS and CDX2-positive AOM populations ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}). Cells at the border of the BRACHYURY-expressing region downregulated the epithelial marker CDH1 and upregulated the mesenchymal marker CDH2 ([Figure 4D,E](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). As in vivo, the outer CDH2 expression domain correlated with the position of the PS (BRACHYURY), embryonic mesoderm (GATA6) and extraembryonic mesoderm (CDX2) populations ([Figure 4F](#fig4){ref-type="fig"}). Furthermore, both the intermediate PS-like domain and the outer embryonic and extraembryonic mesoderm domain expressed SNAIL ([Figure 4---figure supplement 1C--E](#fig4s1){ref-type="fig"}), a transcriptional repressor that regulates the gastrulation EMT ([@bib14]). At 48 hr, CDH2-positive cells emerged at the base of the colony, beneath the CDH1-positive epithelial layer, and were observed more centrally over time ([Figure 4D,E](#fig4){ref-type="fig"}). We also occasionally observed BRACHYURY-expressing cells in more central positions at 72 hr ([Figure 4F](#fig4){ref-type="fig"}), which could suggest an inwards migration of mesenchymal PS derivatives between the upper epithelium and the surface of the micropattern slide. Conversely, central posterior Epi-like cells, maintained CDH1 ([Figure 4D,E](#fig4){ref-type="fig"}).

Various signaling pathways including Wnt, FGF and TGFβ regulate EMT in development and cancer ([@bib28]; [@bib42]; [@bib16]). In particular, the role of TGFβ signaling through SMAD2/3 has been well characterized ([@bib99]). Mice with null mutations in *Smad2*/*3* or *Nodal* do not gastrulate and lack normal mesoderm structures ([@bib24]; [@bib65]; [@bib93]; [@bib17]). To determine whether SMAD2/3 signaling regulated EMT in the in vitro micropattern system, we cultured EpiLC micropatterned colonies in medium containing FGF2, BMP4, WNT3A but lacking ACTIVIN A and supplemented with a small molecule inhibitor of the ALK5 receptor, SB431542 (referred to as ACTIVINi). In the absence of Activin (Nodal) signaling, cells maintained high levels of CDH1 and accumulated at the edge of colonies ([Figure 4G,H](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1F](#fig4s1){ref-type="fig"}). Furthermore, they failed to downregulate SOX2 and did not differentiate, evidenced by the lack of BRACHYURY, GATA6, CDX2 or SOX17 expression ([Figure 4I](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1F](#fig4s1){ref-type="fig"}). Thus, in these flat-disc-shaped micropatterns, SMAD2/3 signaling regulated the EMT associated with an exit from pluripotency and onset of differentiation confirming that in vitro micropattern differentiation and in vivo gastrulation are regulated by common pathways and processes even though their geometries (flat-disc versus cup-shaped) are distinct.

Colony diameter is a critical factor involved in patterning {#s2-7}
-----------------------------------------------------------

It was previously shown that, in the micropattern system, hESCs give rise to the broadest spectrum of cell fates when differentiated within colonies of 500--1000 μm diameter ([@bib91]; [@bib26]). When the micropattern diameter was decreased, the outer cell fate domains were preserved while the inner cell fates were lost, suggesting an edge-sensing input into the differentiation ([@bib91]; [@bib26]). We asked whether colony diameter also affected cell fate specification and patterning of mouse PSCs.

At 72 hr of mouse PSC differentiation on micropatterns of 1000 μm diameter, three concentric domains (Regions A-C) could be defined with respect to SOX2, BRACHYURY and CDX2 expression ([Figures 2F](#fig2){ref-type="fig"} and [5A](#fig5){ref-type="fig"}). The most central domain was Epi-like and predominantly expressed SOX2 (Region A), the mid domain was PS-like and predominantly expressed BRACHYURY (Region B), and the outermost region (Region C) comprised both CDX2-positive extraembryonic mesoderm and GATA6-positive embryonic mesoderm cells ([Figure 5A](#fig5){ref-type="fig"}). While SOX2 levels were highest within the colony center, it was expressed at reduced levels throughout all domains ([Figure 5A,B](#fig5){ref-type="fig"}).

![Smaller diameter colonies pattern in the same order of events but lose central populations.\
(**A**) EpiLCs were differentiated with FGF2 and ACTIVIN A (F/A), BMP4 and WNT3A as described in [Figure 2E](#fig2){ref-type="fig"}. Confocal optical section of a representative 1000 μm diameter colony after differentiation. Dashed circles define 3 regions of distinct marker expression, shown at higher magnification in adjacent panels. While SOX2 is expressed quite broadly, regions were defined based on the marker that was predominantly expressed. Region A (central) = SOX2 (blue), Region B (intermediate) = BRACHYURY (red), Region C (outer) = CDX2 (green). Scale bars, 25 μm. (**B**) Schematic diagram showing the changing marker expression in colonies of different diameters. (**C--F**) Representative confocal maximum intensity projections of colonies at 0, 24, 48 and 72 hr after addition of BMP4 and WNT3A to F/A medium. Images show colonies of 500 μm, 225 μm, 140 μm and 80 μm diameter. Scale bars, 100 μm.](elife-32839-fig5){#fig5}

We noted that the temporal order of differentiation was maintained across the different colony diameters analyzed - 500, 225, 140 and 80 μm ([Figure 5C--E](#fig5){ref-type="fig"}). BRACHYURY-expressing PS-like cells were observed at 24 hr, followed by BRACHYURY/CDX2 coexpression within ACD-like cells at 48 hr and the emergence of cells expressing CDX2 but not BRACHYURY, as in the AOM, at 72 hr ([Figure 5C--D](#fig5){ref-type="fig"}). However, the spatial organization of cell fates after 72 hr of differentiation was dependent on colony diameter ([Figure 5B](#fig5){ref-type="fig"}). Within 500 μm diameter colonies, the outer extraembryonic mesoderm population marked by CDX2 was maintained but, in contrast to colonies of 1000 μm diameter, BRACHYURY-positive PS cells were positioned within the colony center in place of the SOX2 only Epi-like population ([Figure 5B--E](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}).

At even smaller micropattern diameters of 80--140 μm, colonies were comprised predominantly of CDX2 or SOX2 --positive cells with almost no BRACHYURY expression observed ([Figure 5B--E](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). CDX2 and SOX2 marked distinct, apparently randomly positioned, clusters of cells ([Figure 5B--E](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Within 1000 μm diameter colonies, the outer micropattern domain (Region C) was comprised of both embryonic (GATA6) and extraembryonic (SOX17/CDX2) mesoderm populations ([Figure 3F--H](#fig3){ref-type="fig"}). Both embryonic and extraembryonic mesoderm populations were also observed within smaller diameter colonies whereby CDX2 and SOX17 -positive cells were present within distinct domains from cells that expressed GATA6 ([Figure 5F](#fig5){ref-type="fig"}). It should be noted that, on smaller diameter micropatterns, the width to height ratio of colonies was altered such that 80--140 μm diameter colonies generated taller, embryoid body-like aggregates. Over time, these three-dimensional structures exhibited morphological asymmetries ([Figure 5F](#fig5){ref-type="fig"}), which may explain the loss of radial symmetry in marker expression. Colonies of 225 μm diameter patterned cell fates in a manner intermediate to that observed in colonies of 500 μm and 80--140 μm diameter, with some BRACHYURY cells still observed ([Figure 5C--E](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}).

Taken together, these data show that micropattern diameter is a critical factor in determining mouse PSC fate specification and patterning. While the non-uniform, three-dimensional geometry of smaller colonies made data difficult to interpret, the loss of central populations within 500 μm diameter colonies indicates that, like human PSCs ([@bib91]), mouse PSCs may specify fates as a function of distance from the colony edge.

Micropattern colonies exhibit position-dependent BMP signaling {#s2-8}
--------------------------------------------------------------

While the cell culture medium provided homogeneous signals to the micropatterned colonies, different cell fates emerged within distinct radial domains. To determine whether this patterning correlated to a position-dependent interpretation of signals, we focused on BMP, a key upstream signal necessary for gastrulation with an effective antibody readout of activity - nuclear localization of phosphorylated SMAD1/5/8 (pSMAD1/5/8). In vivo, at the early streak stage (E6.5-E6.75), BMP4 is expressed by the ExE and later (E7.5-E8.0) by the allantois and chorion ([@bib51]) ([Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}), and acts on adjacent tissues.

In E6.5-E6.75 embryos, BMP signaling (marked by pSMAD1/5/8) was active at low levels within the proximal, but not distal, Epi and elevated within cells of the PS and embryonic and extraembryonic mesoderm ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}). At this stage, pSMAD1/5/8 levels correlated with BRACHYURY expression ([Figure 6A,B](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1B,C](#fig6s1){ref-type="fig"}). From E7.0 onwards, as the PS extended, pSMAD1/5/8 was observed within the posterior PS but not anterior PS, consistent with anterior cells being positioned furthest from the ExE source of BMP4 ([Figure 6---figure supplement 1D,E](#fig6s1){ref-type="fig"}). Furthermore, pSMAD1/5/8 was observed in embryonic Mesoderm 1 but not BRACHYURY-positive Mesoderm 2 cells and consequently, the correlation with BRACHYURY expression was lost ([Figure 6---figure supplement 1E--G](#fig6s1){ref-type="fig"}).

![BMP signaling in micropatterns and embryos correlates with embryonic and extraembryonic mesoderm fates.\
(**A**) Transverse cryosection of immunostained embryo in [Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}. Scale bar, 50 μm. (**B**) Quantification of pSMAD1/5/8 and BRACHYURY fluorescence intensity in E6.5 embryos. Cells within the epiblast, primitive streak (PS) and mesoderm were manually selected on confocal images of transverse cryosections in ImageJ as shown in right-hand panel. PS = BRACHYURY positive cells at embryo posterior. Mesoderm = cells positioned between VE and Epi. Quantification was carried out on three cryosections per embryo. N, number of cells. Data represents mean fluorescence intensity ± S.D. normalized to Hoechst fluorescence. (**C**) MIPs of immunostained colonies differentiated as in [Figure 2E](#fig2){ref-type="fig"}. Second panel depicts high magnification of colony edge. Scale bars, 100 μm. BRA, BRACHYURY; pS1/5/8, phosphorylated SMAD1/5/8. (**D**) Depiction of spatial patterning across multiple colonies. Each dot represents a single cell. (**E**) Quantification of voxel fluorescence intensity of pSMAD1/5/8 from colony center (0 μm) to edge (500 μm). Data represents average voxel intensity across multiple colonies. pSMAD1/5/8 colony numbers (n) in upper right corner. Data relative to maximum voxel intensity across the time course for each marker.](elife-32839-fig6){#fig6}

At 0 hr of micropattern differentiation, nuclear pSMAD1/5/8 was observed at low levels throughout colonies ([Figure 6C](#fig6){ref-type="fig"}), corresponding to the low BMP signaling activity within the proximal embryonic Epi at E6.5-E6.75 ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}). From 24--72 hr of micropattern differentiation, nuclear pSMAD1/5/8 was elevated at the colony edge within the PS, embryonic and extraembryonic mesoderm cell fate domains ([Figure 6C--E](#fig6){ref-type="fig"}). At 24 and 48 hr, the majority of pSMAD1/5/8-positive cells expressed BRACHYURY but by 72 hr, the fraction of BRACHYURY/pSMAD1/5/8 -positive cells was significantly reduced ([Figure 6C](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1H,I](#fig6s1){ref-type="fig"}). This likely corresponded to the presence of nuclear pSMAD1/5/8, but not BRACHYURY, within Mesoderm 1 cells of the embryo ([Figure 6---figure supplement 1E,F](#fig6s1){ref-type="fig"}).

These data revealed that, as with micropattern differentiated hESCs ([@bib91]; [@bib85]; [@bib26]), signaling activity exhibits radial dependence. Furthermore, the cell types identified within the in vitro micropattern system experienced a comparable BMP signaling history to their in vivo counterparts, with low BMP signaling activity present within posterior Epi-like cells and elevated activity within the posterior PS, embryonic Mesoderm one and extraembryonic mesoderm populations. In vivo, the distal Epi and anterior PS were devoid of BMP activity ([Figure 6---figure supplement 1B,D,E](#fig6s1){ref-type="fig"}) but, in the presence of FGF, ACTIVIN, BMP and WNT, a comparable signaling niche that lacked BMP activity was not observed within the micropatterned colonies.

The spatial organization of hESC-derived cell fates during micropattern differentiation is mediated by a combination of receptor occlusion at the colony center and loss of secreted inhibitors from the colony edge ([@bib85]; [@bib26]). To test for the involvement of receptors in the micropattern organization of mouse cell fates, we substituted exogenous WNT3A with a GSK3 inhibitor, CHIR99021 (CHIR), which circumvents the receptor to activate downstream Wnt pathway components ([Figure 6---figure supplement 2A,B](#fig6s2){ref-type="fig"}). Under these conditions, CDX2, GATA6 and SOX17 were expressed at the outer colony edge indicating that mesoderm differentiation was unaffected ([Figure 6---figure supplement 2C,D](#fig6s2){ref-type="fig"}). However, the BRACHYURY expression territory was expanded throughout the center of the colony ([Figure 6---figure supplement 2E,F](#fig6s2){ref-type="fig"}), recapitulating the expansion of BRACHYURY expression in CHIR-cultured embryos ([@bib82]). These data suggest that the transmission of signals or activity of inhibitors through receptors is key for setting up distinct cell fate domains within the flat-disc micropatterned colonies.

The absence of BMP allows DE and AxM specification {#s2-9}
--------------------------------------------------

BMP, WNT, ACTIVIN and FGF directed micropattern EpiLC differentiation towards posterior embryonic fates (posterior Epi, PS, embryonic and extraembryonic mesoderm), but not cell fates arising from the anterior PS (DE and AxM). Since the anterior PS is devoid of BMP signaling activity, we reasoned that removing BMP would replicate this signaling niche and create an environment permissive to specify anterior, but not posterior fates. EpiLCs were plated onto micropatterns and differentiated for 72 hr with FGF2, ACTIVIN A, BMP4 and WNT3A (referred to as +BMP), FGF2, ACTIVIN A and WNT3A (referred to as -BMP), or FGF2, ACTIVIN A and WNT3A with a small molecule inhibitor of BMP signaling, DMH1 ([@bib4]) (referred to as BMPi) ([Figure 7A](#fig7){ref-type="fig"}). In +BMP conditions, nuclear pSMAD1/5/8 was observed in cells at the perimeter of colonies alongside CDX2 and SOX17, followed by a region of BRACHYURY expression and a central region of cells expressing SOX2 and low levels of FOXA2 ([Figure 7B--E](#fig7){ref-type="fig"}). In medium conditions lacking BMP (-BMP), the absence of BMP signaling activity was confirmed by lack of nuclear pSMAD1/5/8 ([Figure 7B,E](#fig7){ref-type="fig"}). Under these conditions, the domain of extraembryonic mesoderm, marked by CDX2, was lost ([Figure 7C,E](#fig7){ref-type="fig"}). Instead we observed elevated SOX17 in outer cells, which was now robustly coexpressed with FOXA2 ([Figure 7D--F](#fig7){ref-type="fig"}) representing DE ([Figure 3---figure supplement 1E](#fig3s1){ref-type="fig"}). We also observed a separate population of outer cells that coexpressed FOXA2 and BRACHYURY ([Figure 7F,G](#fig7){ref-type="fig"}), likely representing cells within the anterior PS, node or AxM ([Figure 3A](#fig3){ref-type="fig"}, yellow arrowheads,[Figure 3---figure supplement 1F](#fig3s1){ref-type="fig"}).

![Anterior primitive streak fates are specified in the absence of BMP.\
(**A**) EpiLCs generated as in [Figure 1C](#fig1){ref-type="fig"} were plated overnight onto Laminin-coated micropatterns (−24 hr) in N2B27 medium with F/A. Various conditions were used for further differentiation - F/A, BMP4, WNT3A (+BMP), F/A, WNT3A (-BMP) or F/A, WNT3A with DMH1 BMP signaling inhibitor (BMPi). Colonies were analyzed after 72 hr differentiation. (**B--D, G**). MIPs of immunostained 72 hr colonies. Scale bars, 100 μm. (**E**) Quantification of immunostaining. Voxel fluorescence intensity was measured from colony center (0) to edge (500). Data represents average voxel intensity across multiple colonies relative to maximum voxel intensity for each marker. (**F**) Quantification of marker coexpression by voxel. Each dot indicates fluorescence intensity of a single voxel. Color represents voxel density within the plot. Numbers within quadrants show % of voxels within the gate. N, number of colonies. (**H**) Schematic diagram summarizing the cell fates observed after 72 hr in vitro differentiation under conditions described in A and corresponding in vivo cell types at E7.75-E8.0. The outer domain of the micropattern colony comprises cells that coexpress SOX17 and FOXA2, representing definitive endoderm and cells that coexpress BRACHYURY and FOXA2, representing anterior primitive streak or axial mesoderm cells.](elife-32839-fig7){#fig7}

To further investigate the anterior cell fates formed in the absence of BMP, we differentiated *Gsc^GFP/+^; Hhex^RedStar/+^* ESCs for 72 hr in the presence of FGF, ACTIVIN and WNT. While in the presence of BMP4, *Hhex^RedStar^* but not *Gsc^GFP^* was expressed ([Figure 3---figure supplement 2B](#fig3s2){ref-type="fig"}), in the absence of BMP, we observed FOXA2, BRACHYURY and *Gsc^GFP^* expression at the edge of micropatterned colonies from 24 hr of differentiation, followed by *Hhex^RedStar^* expression at 48 hr ([Figure 7---figure supplement 1A--C](#fig7s1){ref-type="fig"}). The number of FOXA2, BRACHYURY, *Gsc^GFP^* and *Hhex^RedStar^* -expressing cells increased over time. The majority of *Hhex^RedStar^*-positive cells coexpressed *Gsc^GFP^* and FOXA2 ([Figure 7---figure supplement 1D,E](#fig7s1){ref-type="fig"}) a signature of both DE and AxM. However, as we observed little overlap between *Gsc^GFP^*, *Hhex^RedStar^* and the AxM marker BRACHYURY within individual cells ([Figure 7---figure supplement 1F,G](#fig7s1){ref-type="fig"}), *Gsc^GFP^*/*Hhex^RedStar^*/FOXA2 coexpression likely represented DE. The FOXA2/BRACHYURY-coexpressing cells observed in the absence of BMP ([Figure 7F,G](#fig7){ref-type="fig"}) may correspond to a subpopulation of anterior PS cells ([Figure 3A](#fig3){ref-type="fig"}) or alternatively AxM cells that have downregulated *Gsc* and *Hhex*. Global transcriptional analysis may be required to resolve these possibilities. We also frequently observed cells that coexpressed *Gsc^GFP^* and FOXA2 but not *Hhex^RedStar^* ([Figure 7---figure supplement 1D](#fig7s1){ref-type="fig"}), which may represent a BRACHYURY negative anterior PS-like state ([Figure 3A](#fig3){ref-type="fig"}) ([@bib12]).

In conditions lacking BMP signaling activity, SOX2 levels were elevated relative to those in the presence of BMP ([Figure 7B--E](#fig7){ref-type="fig"}). This suggested that central cells represent a more anterior Epi state. To determine whether this was the case, we utilized a *Sox1^GFP^* fluorescent reporter ESC line ([@bib100]). *Sox1^GFP^* marks early neurectoderm specification from cells within the anterior Epi ([@bib100]). We differentiated *Sox1^GFP^* ESCs as described in [Figure 7A](#fig7){ref-type="fig"}, either in the presence or absence of BMP. As with other cell lines analyzed, in the presence of BMP cells within the outer domain of *Sox1^GFP^* EpiLC micropatterned colonies expressed CDX2 and, in the absence of BMP, they expressed FOXA2 ([Figure 7---figure supplement 2A,C](#fig7s2){ref-type="fig"}). While *Sox1^GFP^* was largely absent from micropatterned colonies in the presence of BMP, consistent with the colony center representing posterior Epi, in the absence of BMP *Sox1^GFP^* was expressed at high levels throughout the colony center ([Figure 7---figure supplement 2B,C](#fig7s2){ref-type="fig"}). Furthermore, in the absence of BMP, OTX2 levels were also elevated, with the highest expression observed at the colony periphery within the domain corresponding to DE and AxM fates ([Figure 7---figure supplement 2B,C](#fig7s2){ref-type="fig"}). This agrees with the later embryonic expression of OTX2 within the DE ([Figure 7---figure supplement 2D](#fig7s2){ref-type="fig"}). Hence, removing BMP from the (FGF, ACTIVIN and WNT) growth factor cocktail promoted differentiation towards anterior Epi, DE and anterior PS and/or AxM fates ([Figure 7H](#fig7){ref-type="fig"}, [Table 1](#table1){ref-type="table"}).

Epiblast stem cells form definitive endoderm in the presence and absence of BMP {#s2-10}
-------------------------------------------------------------------------------

EpiSCs, maintained under standard FGF and ACTIVIN (F/A) culture conditions ([@bib84]; [@bib11]), correlate to later embryonic stages than EpiLCs do ([@bib35]). While EpiLCs represent the pre-gastrulation Epi, EpiSCs are similar to the Epi during gastrulation and express markers associated with the anterior PS ([@bib48]). We therefore asked whether EpiSCs demonstrated a distinct differentiation capacity from EpiLCs in the context of the micropattern system.

EpiSC9 cells ([@bib64]) were cultured in defined medium with 12 ng/ml FGF2 and 20 ng/ml ACTIVIN A. EpiSCs were plated onto the micropatterns as described for EpiLCs and differentiated in the same manner - for 72 hr in the presence or absence of BMP ([Figure 8A](#fig8){ref-type="fig"}). In the presence of BMP, differentiated EpiSC colonies showed an elevated expression of lineage-associated markers, including BRACHYURY, GATA6, FOXA2 and SOX17, at the colony periphery but lacked obvious spatial organization within more central regions ([Figure 8B,C](#fig8){ref-type="fig"}). GATA6 and SOX17/FOXA2 expression represented a DE fate while BRACHYURY was expressed at the outer colony edge in the same domain as FOXA2 corresponding to anterior PS or AxM cell types. SOX2-expressing cells were also present, likely representing an Epi-like state ([Figure 8B](#fig8){ref-type="fig"}). Under these conditions, EpiSCs generated few CDX2-positive cells indicating a significant reduction in the formation of extraembryonic mesoderm ([Figure 8B](#fig8){ref-type="fig"}). In the absence of BMP, GATA6, FOXA2 and SOX17 were expressed more uniformly throughout the colonies ([Figure 8B,C](#fig8){ref-type="fig"}). Hence, unlike EpiLCs, EpiSCs specified anterior cell fates both in the presence and absence of BMP.

![Epiblast stem cells undergo definitive endoderm differentiation in the presence or absence of BMP.\
(**A**) Epiblast stem cells (EpiSCs) of the EpiSC9 line ([@bib64]) were cultured in the presence of 12 ng/ml FGF2 and 20 ng/ml ACTIVIN A (F/A) on fibronectin. EpiSCs were then plated overnight onto Laminin-coated micropatterns (−24 hr) in N2B27 medium with F/A. Various conditions were used for further differentiation - F/A, BMP4, WNT3A (+BMP) or F/A, WNT3A (-BMP). Colonies were analyzed after 72 hr differentiation. (**B**) MIPs of immunostained 72 hr colonies. Scale bars, 100 μm. (**C**) Quantification of immunostaining. Voxel fluorescence intensity was measured from colony center (0) to edge (500). Data represents average voxel intensity across multiple colonies (n = 10/condition) and is shown relative to maximum voxel intensity for each marker across both conditions. (**D**) Graphs showing the expression level of a number of genes from the published microarray dataset of Hayashi et al. from E5.75 in vivo epiblast, EpiLCs and EpiSCs ([@bib35]). Data shown is from amplified RNA samples and represents the mean ± S.D for two independent replicates.](elife-32839-fig8){#fig8}

We then utilized published microarray data from Hayashi et al ([@bib35]), comparing the pre-gastrulation E5.75 Epi, EpiLCs and EpiSCs, to ask what may underlie this difference in the micropattern differentiation of EpiLCs and EpiSCs. As previously described ([@bib35]; [@bib48]) the E5.75 Epi, EpiLCs and EpiSCs all express high levels of the pluripotency marker *Pou5f1,* but EpiSCs also express high levels of the anterior markers *Foxa2* and *Sox17* ([Figure 8D](#fig8){ref-type="fig"}). Furthermore, EpiSCs show a marked increase in the expression of the BMP pathway inhibitor *Chordin*, the Wnt pathway inhibitor *Dkk1*, and the Nodal pathway inhibitor *Lefty2* ([Figure 8D](#fig8){ref-type="fig"}) that, in this context, may render EpiSCs unresponsive to the BMP posteriorization signal.

Discussion {#s3}
==========

We have developed a robust, quantitative and scalable micropattern protocol promoting the organized differentiation of mouse EpiLCs, the in vitro counterpart of the pre-gastrulation pluripotent Epi of the embryo ([@bib35]). In response to FGF, ACTIVIN (NODAL), BMP and WNT, the critical gastrulation-inducing signals acting in the mouse embryo ([@bib5]), EpiLCs grown on circular micropatterns underwent reproducible spatially coordinated cell fate specification comparable to in vivo gastrulation. Detailed marker analysis of gastrulating mouse embryos (which allow the mapping not only of marker expression but also of cell position) and micropatterns allowed us to link the in vitro differentiation to in vivo developmental time and space. In the absence of the spatial and temporal information of the embryo, we defined a cohort of 15 markers (SOX2, POU5F1, NANOG, SOX1, OTX2, BRACHYURY, CDX2, GATA6, SOX17, FOXA2, FOXF1, CDH1, CDH2, SNAIL, pSMAD1/5/8) that allowed us to distinguish between cell fates such as anterior versus posterior Epi, or extraembryonic mesoderm versus trophectoderm and DE, as these cell types express many common factors. This emphasizes the necessity of expression signatures, rather than individual markers, to accurately assign cell fates in vitro.

During 72 hr of differentiation, micropatterned colonies advanced from an E5.5 pluripotent Epi-like state to comprising an array of populations present in the embryo just prior to E7.75 ([Figure 9A](#fig9){ref-type="fig"}). Hence, under these culture conditions, in vitro cellular differentiation was slower than in vivo development. Conceivably, further manipulation of the timing, levels and combination of signaling factors provided to EpiLCs, as well as the extracellular matrix composition and stiffness of the substrate on which cells are maintained to more closely mimic that of the embryo, could alter the rate of differentiation and support the specification of cell fates emerging at later gastrulation stages.

![Micropattern differentiation of mouse pluripotent stem cells recapitulates cell fate specification in the posterior or anterior primitive streak.\
(**A**) Summary of embryo gastrulation (upper) and correlation with in vitro micropattern differentiation (lower). With FGF2, ACTIVIN A, BMP4 and WNT3A, mouse PSC differentiation recapitulated differentiation in the proximal posterior of the gastrulating embryo. Epi-like cells (EpiLCs) correlated to the embryonic day (**E**) 5.5--6.0 pre-streak epiblast (Epi). After 24 hr, cells in the colony center adopted a posterior Epi (P-Epi) identity and a primitive streak (PS)-like population arose at the colony edge, as E6.25-E6.5. After 48 hr, clusters of cell populations emerged at the outer colony edge correlating to embryonic Mesoderm 1 (Meso), and extraembryonic mesoderm (ExM) allantois core domain (ACD) arising at E6.75-E7.0. After 72 hr, cells in the colony center represented the distal P-Epi of E7.0-E7.25 embryos. Meso, ExM and PS populations were maintained. However, ACD cells were replaced by cells with an allantois outer mesenchyme (AOM) identity. Cells were highly confluent and could not be maintained under these conditions after 72 hr. LO, low expression. Dashed lines mark transverse plane shown below. (**B**) Summary of correlation between in vitro micropattern differentiation with FGF, ACTIVIN and WNT and in vivo gastrulating embryos. Under these conditions, mouse PSCs recapitulated differentiation of distal posterior (left panels) or distal posterior and anterior of embryo. After 72 hr, the central population expressed elevated levels of SOX2 compared to BMP4 conditions, likely representing anterior Epi (A-Epi). Cells coexpressed FOXA2, SOX17, *Gsc* and *Hhex* representing definitive endoderm (DE), FOXA2 and BRACHYURY representing anterior PS (A--PS) or AxM and or FOXA2 and *Gsc* likely representing A-PS. HI, high expression. A, anterior; P, posterior; Pr, proximal; D, distal. Color-coded legends highlight key markers of different cell states at each time point. (**C**) Box plots showing Epi length along the anterior-posterior (**A--P**) axis at pre- (E5.5-E6.0) early (E6.5-E6.75), mid- (E7.0-E7.5) and late (E7.75-E8.0) streak stages of mouse embryonic development. The A-P length was measured on sagittal confocal optical sections through the middle of the embryo with ImageJ software, as depicted in the schematic diagram. N, number of embryos. (**D**) Box plots showing human embryonic disc measurements compiled from human embryo data collections. Abnormal embryo data were excluded. D = embryonic day. Carnegie stage 6a, pre-streak; 6b, early streak; 7, early-mid gastrulation.](elife-32839-fig9){#fig9}

At 72 hr, micropatterned colonies could be divided into three spatially distinct domains (central, mid and outer) ([Figure 9A](#fig9){ref-type="fig"}). Cells within the colony center showed minimal BMP signaling and expressed posterior Epi markers. PS markers were initially expressed at the periphery, but over time were observed more centrally. This was accompanied by an EMT and the emergence of outer mesenchymal cells, plausibly emanating from the PS-like region. The outer domain displayed elevated BMP activity and contained multiple populations including allantois and yolk sac extraembryonic mesoderm and early embryonic mesoderm.

In contrast to most gastrulating viviparous mammalian embryos, which exhibit a flat-disc geometry, rodents including the mouse are cup-shaped. A conceptual flattening of the cell fate arrangement within the mouse embryo ([@bib9]), could not fully recapitulate the organization of cell types observed within the flat-disc micropatterns. Therefore the most evident correspondence between embryonic and micropattern cell fates was signaling history. However, while all cells within the outer micropattern domain experienced high levels of BMP signaling, both embryonic and extraembryonic mesoderm fates were specified. It is therefore unclear whether additional morphogens distinguish embryonic and extraembryonic mesoderm, or if factors such as three dimensional growth, migration and extracellular matrix composition or substratum stiffness dictate fate. Extension of the micropattern system to different geometries, morphogens and inhibitors should resolve these questions.

Spatial organization of cell identities within the micropatterns emerged even though signals were provided uniformly. Thus, epithelial cell cultures can self-organize and the signaling history of a cell depends on its local environment, as well as the external medium. When WNT3 was replaced with CHIR ([@bib96]) a small molecule that activates the WNT signaling pathway intracellularly, bypassing the receptors and secreted inhibitors acting at the cell surface, the PS region expanded into the colony center. Hence, as with human micropattern differentiation ([@bib91]), endogenously produced inhibitors likely exclude signals from the colony center to define the inner domains. The identity of these inhibitors represents an open question to be elucidated in future studies.

In vivo, localized signaling from the extraembryonic tissues, notably the anterior visceral endoderm (AVE), induces molecular asymmetries within the bilaterally symmetrical Epi leading to anterior-posterior axis establishment ([@bib81]). As the described micropattern system does not contain extraembryonic VE or ExE cells, and the disc-shaped colonies are also morphologically symmetrical, there is no apparent chemical or physical source of symmetry-breaking. Therefore, micropattern-differentiated PSCs might generate radially symmetric cell fate domains and be reminiscent of mutant embryos with defects in AVE specification or positioning ([@bib66]; [@bib55]; [@bib46]; [@bib21]), that lack the endogenous source of symmetry breaking. Interestingly, a mouse PSC-based three-dimensional differentiation system involving embryoid body-like aggregates, demonstrated asymmetric lineage marker expression in the absence of extraembryonic cell types ([@bib88]). However, as these structures are not geometrically uniform, the polarized marker expression likely stems from initial morphological asymmetries and there is still no evidence of spontaneous symmetry breaking within geometrically uniform structures.

The cohort of signaling factors and secreted inhibitors expressed by adjacent tissues within the embryo make development robust yet difficult to quantify. For example, the extraembryonic VE is a source of inhibitors including CERBERUS and LEFTY1 on the anterior ([@bib81]), and WNT3 on the posterior ([@bib71]) side of the embryo, whereas the Epi and its derivatives express WNT3, LEFTY2 and DKK1 ([@bib69]; [@bib54]). As our in vitro system patterns in the absence of extraembryonic cell types, it allows us to decipher Epi-intrinsic patterning mechanisms.

The micropattern system can be used to extend findings in animal models to a defined, serum-free environment where signaling modulation can be unambiguously interpreted to reveal how timing and levels of signaling influence cell fate. As a first step in this direction, we analyzed the effect of manipulating the BMP pathway. Embryos with disrupted BMP signaling do not form a morphological PS and predominantly arrest at early gastrulation ([@bib31]; [@bib56]; [@bib57]; [@bib95]), obscuring the assessment of a role for BMP in later mesoderm and endoderm specification. When we applied FGF, ACTIVIN and WNT alone (in the absence of BMP) to micropatterned colonies, anterior rather than posterior cell fates were specified ([Figure 7B](#fig7){ref-type="fig"}). These data revealed that BMP is not significantly induced by WNT and its absence does not perturb anterior cell fate specification. In the future, the micropattern assay could be used as a robust, efficient and scalable way to survey signaling conditions and systematically screen interactions between individual genes and pathways.

While a spectrum of mouse PSC states have been captured in vitro ([@bib59]), their comparative functional capacities and relation to the embryo is largely unknown. The micropattern system represents a quantifiable means to test the differentiation potential of PSC states and cell lines under defined conditions. Here we observed that EpiLCs patterned either posterior or anterior cell fates in the presence or absence of BMP respectively. Conversely, although EpiSCs can contribute to all germ layers in chimaera assays ([@bib39]), within the micropattern system they predominantly generated DE cells and exhibited minimal self-organization. The limited capacity of EpiSCs to pattern in isolation may stem from their elevated expression of signaling inhibitors ([@bib35]). Alternatively, exogenous FGF, ACTIVIN, BMP and WNT may not be sufficient to induce the expression of secondary factors required for patterning and posterior cell fate specification of EpiSCs. Further manipulation of the micropattern differentiation conditions may give novel insights into the unique requirements of these different pluripotent cell states ([Figure 1A](#fig1){ref-type="fig"}) for organized cell fate specification.

Due to a paucity of data on gastrulating human embryos, cell fates arising during hESC micropattern differentiation can only been predicted ([@bib91]; [@bib26]). The mouse micropattern differentiation provides the essential missing link between in vitro gastrulation models in mouse and human, and in vivo mouse development. The identification of an extraembryonic mesoderm population within mouse, but not human micropatterns prompts an analysis of the human system with equivalent marker combinations under comparable serum-free medium conditions containing both BMP4 and WNT3A to determine whether populations such as extraembryonic mesoderm can be generated, or whether in human, extraembryonic mesoderm, as has been shown for the amnion ([@bib22]), does not arise from the Epi at gastrulation. Human and mouse embryos are of a similar size ([Figure 8C,D](#fig8){ref-type="fig"}), their corresponding in vitro PSCs undergo micropattern differentiation within equivalent diameter colonies and specify cell fates as a function of distance from the colony edge, suggesting that these species use common mechanisms to regulate cell fate specification and tissue patterning. The further correlation of mouse and human in vitro micropattern data, in the context of different pluripotent starting states, and corroborated with in vivo data from mouse embryos should yield insights into the conserved and divergent mechanisms regulating fundamental aspects of early mammalian development.

Materials and methods {#s4}
=====================

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species) or\                   Designation                     Source or reference                                            Identifiers                                                                        Additional information
  resource                                                                                                                                                                                                                       
  -------------------------------------------- ------------------------------- -------------------------------------------------------------- ---------------------------------------------------------------------------------- --------------------------------------------
  Strain, strain background (*Mus musculus*)   Crl:CD1\                                                                                       RRID:[IMSR_CRL:22](https://scicrunch.org/resolver/IMSR_CRL:22)                     CD1 *Mus musculus* wild-type outbred mouse
                                               (ICR)                                                                                                                                                                             

  Cell line (*Mus musculus*)                   ES-E14                          ([@bib37])                                                     RRID:[CVCL_C320](https://scicrunch.org/resolver/CVCL_C320)                         Embryonic stem cell line:*Mus musculus*

  Cell line (*Mus musculus*)                   ES-R1                           ([@bib63])                                                     RRID:[CVCL_2167](https://scicrunch.org/resolver/CVCL_2167)                         Embryonic stem cell line:*Mus musculus*

  Cell line (*Mus musculus*)                   *Sox17^GFP/+^*                  ([@bib45])                                                                                                                                        Embryonic stem cell line:*Mus musculus*

  Cell line (*Mus musculus*)                   *T^GFP/+^*                      ([@bib1])                                                                                                                                         Embryonic stem cell line: *Mus musculus*

  Cell line (*Mus musculus*)                   46 C cell line (*Sox1^GFP^*)    ([@bib100])                                                    RRID:[CVCL_Y482](https://scicrunch.org/resolver/CVCL_Y482)                         Embryonic stem cell line:*Mus musculus*

  Cell line (*Mus musculus*)                   *Gsc^GFP/+^; Hhex^RedStar/+^*   ([@bib89])                                                                                                                                        Embryonic stem cell line:*Mus musculus*

  Cell line (*Mus musculus*)                   EpiSC9                          ([@bib64])                                                                                                                                        Epiblast stem cell line: *Mus musculus*

  Antibody                                     anti-BRACHYURY                  R and D Systems                                                Cat\# AF2085, RRID:[AB_2200235](https://scicrunch.org/resolver/AB_2200235)         1:200

  Antibody                                     anti-CDH1                       Sigma-Aldrich                                                  Cat\# U3254, RRID:[AB_477600](https://scicrunch.org/resolver/AB_477600)            1:500

  Antibody                                     anti-CDH2                       Santa Cruz Biotechnology                                       Cat\# sc-7939, RRID:[AB_647794](https://scicrunch.org/resolver/AB_647794)          1:300

  Antibody                                     anti-CDX2                       BioGenex                                                       Cat\# AM392, RRID:[AB_2650531](https://scicrunch.org/resolver/AB_2650531)          1:200

  Antibody                                     anti-DsRed                      Clontech Laboratories, Inc.                                    Cat\# 632496, RRID:[AB_10013483](https://scicrunch.org/resolver/AB_10013483)       1:500

  Antibody                                     anti-FOXA2                      Abcam                                                          Cat\# ab108422, RRID:[AB_11157157](https://scicrunch.org/resolver/AB_11157157)     1:500

  Antibody                                     anti-FOXF1                      R and D Systems                                                Cat\# AF4798, RRID:[AB_2105588](https://scicrunch.org/resolver/AB_2105588)         1:200

  Antibody                                     anti-GATA6                      R and D Systems                                                Cat\# AF1700, RRID:[AB_2108901](https://scicrunch.org/resolver/AB_2108901)         1:100

  Antibody                                     anti-GATA6                      Cell Signaling Technology                                      Cat\# 5851, RRID:[AB_10705521](https://scicrunch.org/resolver/AB_10705521)         1:500

  Antibody                                     anti-GFP                        Aves Labs                                                      Cat\# GFP-1020, RRID:[AB_10000240](https://scicrunch.org/resolver/AB_10000240)     1:500

   antibody                                    anti-KLF4                       R and D Systems                                                Cat\# AF3158, RRID:[AB_2130245](https://scicrunch.org/resolver/AB_2130245)         1:200

  Antibody                                     anti-NANOG                      Thermo Fisher Scientific                                       Cat\# 14-5761-80, RRID:[AB_763613](https://scicrunch.org/resolver/AB_763613)       1:200

  Antibody                                     anti-NANOG                      Cosmo Bio Co                                                   Cat\# REC-RCAB0002PF, RRID:[AB_567471](https://scicrunch.org/resolver/AB_567471)   1:500

  Antibody                                     anti-OTX2                       R and D Systems                                                Cat\# AF1979, RRID:[AB_2157172](https://scicrunch.org/resolver/AB_2157172)         1:500

  Antibody                                     anti-POU3F1                     Millipore Sigma                                                MABN738                                                                            1:100

  Antibody                                     anti-POU5F1                     Santa Cruz Biotechnology                                       Cat\# sc-5279, RRID:[AB_628051](https://scicrunch.org/resolver/AB_628051)          1:100

  Antibody                                     anti-pSMAD1/5/8                 a gift from Dr. Ed Laufer, Columbia University, New York, NY   N/A                                                                                1:200

  Antibody                                     anti-SNAIL                      R and D Systems                                                Cat\# AF3639, RRID:[AB_2191738](https://scicrunch.org/resolver/AB_2191738)         1:100

  Antibody                                     anti-SOX2                       Thermo Fisher Scientific                                       Cat\# 14-9811-82, RRID:[AB_11219471](https://scicrunch.org/resolver/AB_11219471)   1:200

  Antibody                                     anti-SOX17                      R and D Systems                                                Cat\# AF1924, RRID:[AB_355060](https://scicrunch.org/resolver/AB_355060)           1:200

  Software, algorithm                          Ilastik                         <http://ilastik.org/>                                          RRID:[SCR_015246](https://scicrunch.org/resolver/SCR_015246)                       3-D Nuclear mask generation
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Gene and gene product nomenclature {#s4-1}
----------------------------------

Genes and gene products are referred to using guidelines set by the International Committee on Standardized Genetic Nomenclature for Mice - gene symbols are italicized with only the first letter upper case while proteins are all upper case and no italics (<http://www.informatics.jax.org/mgihome/nomen/gene.shtml>). Cytokines are referred to as proteins (all upper case) while the corresponding signaling pathways are referred to in lower case, non-italic.

Cell culture {#s4-2}
------------

ESC lines used for this study include E14 (129/Ola background) ([@bib37]), R1 (129/Sv background) ([@bib63]), *Sox17^GFP/+^* (R1, 129/Sv background) ([@bib45]), *T^GFP/+^* (E14.1, 129/Ola background, also known as GFP-Bry) ([@bib27]) and *Sox1^GFP^* (E14Tg2a background, also known as 46C) ([@bib100]), *Gsc^GFP/+^; Hhex^RedStar/+^* (E14Tg2a background) ([@bib89]). ESCs were routinely cultured on 0.1% gelatin coated tissue culture grade plates (Falcon, Tewksbury, MA) in serum and LIF medium as previously described ([@bib60]). Serum and LIF medium was comprised of Dulbecco's modified Eagle's medium (DMEM) (Gibco, Gaithersburg, MD) containing 0.1 mM non-essential amino-acids (NEAA), 2 mM glutamine and 1 mM sodium pyruvate, 100 U/ml Penicillin, 100 μg/ml Streptomycin (all from Life Technologies, Carlsbad, CA), 0.1 mM 2-mercaptoethanol (Sigma, St. Louis, MO), and 10% Fetal Calf Serum (FCS, F2442, Sigma) together with 1000 U/ml LIF. They were passaged every 2 days upon reaching approximately 80% confluence by washing with phosphate buffered saline (PBS) before adding 0.05% Trypsin (Life Technologies) for 3 min at 37°C and dissociating into a single cell suspension by pipetting. Trypsin activity was then neutralized with serum-containing medium. Cells were collected at 1300 rpm for 3 min and 1/5 of cells transferred to a new plate.

For this study, the EpiSC9 epiblast stem cell line was used (129SvEv x ICR background) ([@bib64]). EpiSCs were cultured under standard conditions as previously described ([@bib11]), in defined, serum-free N2B27 medium with 12 ng/ml FGF2 and 20 ng/ml ACTIVIN A. EpiSCs were passaged upon reaching approximately 80% confluence by washing with PBS then replacing with Accutase (Sigma) and scraping cells from the plate. Cells were pipetted gently to avoid single cell dissociation. Cells were collected at 1300 rpm for 3 min and 1/5 of cells transferred to a new plate. ESCs and EpiSCs were maintained at 37°C at 5% CO~2~ and 90% humidity.

EpiLC conversion {#s4-3}
----------------

Prior to plating on micropatterns, ESCs were converted to a transient EpiLC state as previously described ([@bib35]). First, 10 cm plates were coated with 16 μg/ml of Fibronectin (FC010, Millipore Sigma, Billerica, MA) for 1 hr at room temperature followed by two washes with PBS. ESCs were collected by trypsinization (see above), counted and 1.6 × 10^6^ cells plated onto the Fibronectin-coated plates for 48 hr in EpiLC medium, N2B27 medium containing 20 ng/ml ACTIVIN A and 12 ng/ml FGF2 (Peprotech, Rocky Hills, NJ). Medium was changed daily.

Micropattern differentiation {#s4-4}
----------------------------

To coat micropatterned surfaces, a solution was prepared of 20 μg/ml Laminin (L20202, Sigma) in PBS without calcium and magnesium (PBS-/-). A 15 cm tissue culture plate was lined with Parafilm (Pechiney Plastic Packaging, Chicago, IL) and 700 μl drops were made onto the Parafilm surface. Micropatterned chips (Arena A, CYTOO, France) were washed once with PBS-/- and then inverted on top of the drops followed by incubation at 37°C for 2 hr. Micropatterns were then washed 5 times with 5 ml of PBS-/-. EpiLCs were collected by trypsinization and a single cell suspension generated. Cells were counted and 2 × 10^6^ EpiLCs were evenly plated onto micropatterns within 6-well plates (Falcon) in EpiLC medium. Medium was supplemented with a small molecule inhibitor of Rho-associated kinase (ROCKi, 10 μM Y-27632, Tocris Bioscience, UK) for the first 2 hr after plating, to reduce apoptosis ([@bib67]; [@bib92]). Plates were maintained in the tissue culture hood for 30 min after plating to allow time for cells to evenly adhere to the micropatterns before moving to the incubator. After 2 hr, medium containing ROCKi was exchanged for N2B27 medium containing 12 ng/ml FGF2, 20 ng/ml ACTIVIN A, 50 ng/ml BMP4 (Peprotech) and 200 ng/ml WNT3A (R and D, Minneapolis, MN). Cells were maintained for up to 72 hr in this state, after which time cells were highly confluent and cell death was observed. To determine the effect of BMP signaling on the differentiation, cells were differentiated as described above for 72 hr with FGF, ACTIVIN, BMP and WNT (+BMP) or with FGF2, ACTIVIN A and WNT3A without BMP4 (-BMP) or FGF, ACTIVIN and WNT with the addition of 2 μM DMH1 (Sigma) (BMPi).

Immunostaining, imaging and quantification of cells {#s4-5}
---------------------------------------------------

Prior to immunostaining, cells were either grown on micropatterns or in 1 μ-slide eight well IbiTreat plates (Ibidi, Germany). Cells were washed twice with PBS before being fixed with 4% paraformaldehyde (PFA) (Electron Microscopy Sciences, Hatfield, PA) at room temperature for 15 min. Cells were then washed a further two times with PBS followed by permeabilization with PBS containing 0.1% Triton-X (Sigma) (PBS-T) for 10 min at room temperature. Cells were then blocked in PBS-T with 1% bovine serum albumin (BSA, Sigma) and 3% donkey serum (Sigma) for 30 min at room temperature. Primary antibodies were added overnight at 4°C, diluted to the appropriate concentration in PBS-T with 1% BSA. Details of primary antibodies are supplied in Key Resources Table. The following day, cells were washed three times for 15 min with PBS followed by incubation with secondary antibodies (1:500, Alexa Fluors, Life Technologies, Dylight, Jackson ImmunoResearch) in PBS-T with 1% BSA for 2 hr at room temperature. Finally, cells were washed three times for 15 min with PBS with the final wash containing 5 μg/ml Hoechst (Life Technologies). Cells grown on micropatterns were then mounted onto glass slides (Fisher Scientific, Hampton, NH) with Fluoromount-G (Southern Biotech, Birmingham, AL). Cells were imaged using a LSM880 confocal (Zeiss). Brightfield-only images were acquired using a Zeiss Axio Vert.A1.

Quantitative analysis of micropattern differentiation {#s4-6}
-----------------------------------------------------

For micropattern image analysis and quantification, tiled Z-stack images of individual colonies were collected using a LSM880 confocal microscope (Zeiss) at 512 × 512 format using a 20x objective. The background signal was subtracted using ImageJ software and each channel saved as a separate tiff file. Tiff files containing the Hoechst nuclear staining of each colony were classified into regions containing nuclei and those that did not using Ilastik ([@bib80]), an interactive image classification software. Using this information, a 3D probability mask was generated and analysis carried out using custom software written in Python. All analysis was carried out on entire Z-stacks of multiple colonies and an average of results across colonies displayed.

Segmentation of individual cells within images of colonies proved problematic due to the large number and high density of cells. For these reasons, manual correction of segmentation, as routinely used in smaller systems ([@bib76]), was not feasible. Therefore quantification of immunostaining fluorescence intensity across the radii of colonies as well as coexpression analysis was completed on a voxel basis to eliminate segmentation artifacts. To generate plots of radial immunostaining fluorescence intensity, each voxel within a colony was assigned a distance from the colony center. The fluorescence intensity for each marker was measured per voxel and then the average fluorescence intensity of voxels at a particular radial position (binned into discrete radial bands) was calculated for each colony. The average radial fluorescence intensity across multiple colonies was then calculated. To display the expression of multiple different markers across the radii of colonies on the same scale, the relative level of each marker was quantified by normalizing to the highest level of expression (shown as 100) either across a time-course or within an individual time-point. Spatial patterning across multiple colonies was also demonstrated by generating average colony images for individual markers where each segmented cell was represented as a dot whose color indicates its fluorescence in the specified channel.

Coexpression analysis was carried out on a voxel level, that is the fluorescence level of each marker within a single voxel was calculated and plotted. For genes that were not expressed, or only expressed at low levels, at the start of the differentiation, gates could be drawn based on the fluorescence at 0 hr and used to quantify the percentage of total voxels expressing a particular marker at later time points.

Nuclear density measurements in micropatterns and embryos {#s4-7}
---------------------------------------------------------

The number of nuclei per 100 μm was quantified for 0 hr and 24 hr of micropattern differentiation utilizing the colony side view (z-axis) from confocal images acquired using a 40x objective at 0.5 μm interval steps. The number of nuclei was quantified across the entire width of the colony at 10 distinct positions and the average number of nuclei per 100 μm distance were calculated. For E5.5 embryos, the number of nuclei per 100 μm was quantified on sagittal confocal optical sections based on the number of nuclei within a sagittal optical section of the epiblast and the distance around the epiblast within the same section, manually measured using ImageJ software. For E6.5 the same was done using confocal images of transverse cryosections. Only cells within the epiblast were counted. Five embryos at E5.5 and five at E6.5 were analyzed in this manner.

Inter-nuclear distance was manually measured using ImageJ software. A line was drawn from the center of one nuclei to the center of the adjacent nuclei. For micropattern differentiation, 150 measurements were made per time point (0 hr and 24 hr). For in vivo data, five different embryos were measured at each time point (E5.5 and E6.5). At E5.5, 125 measurements were made and at E6.5, 189 measurements were made.

Mice {#s4-8}
----

All mice used in this study were of a wild-type CD1 background. Mice were maintained in accordance with the guidelines of the Memorial Sloan Kettering Cancer Center (MSKCC) Institutional Animal Care and Use Committee (IACUC). Mice were housed under a 12 hr light/dark cycle in a specific pathogen free room in the designated facilities of MSKCC. Natural matings of CD1 males and 4--6 weeks old virgin CD1 females were set up in the evening and mice checked for copulation plugs the next morning. The date of vaginal plug was considered as E0.5.

Immunostaining and imaging of embryos {#s4-9}
-------------------------------------

To analyze the expression of markers within post-implantation embryos, the uterus of pregnant mice was dissected and deciduae removed. Embryos were dissected from the deciduae and the parietal endoderm removed. Embryos were washed twice in PBS and fixed in 4% PFA for 30 min at room temperature. Embryos were permeabilized in PBS with 0.5% Triton-X for 30 min followed by blocking overnight in PBS-T with 5% horse serum (Sigma). Primary antibodies were added the following day, diluted in blocking buffer at the appropriate concentration (details can be found in Key Resources Table) and incubated overnight at 4°C. The next day, embryos were washed 3 times for 15 min in PBS-T and then blocked for a minimum of 2 hr. Embryos were then incubated with the secondary antibodies diluted in blocking buffer overnight at 4°C. Alexa Fluor (Thermo Fisher Scientific) secondary antibodies were diluted 1:500. The following day, embryos were washed 3 times for 15 min in PBS-T with the last wash containing 5 μg/ml Hoechst. Embryos were imaged in PBS-T in glass bottom dishes (MatTek, Ashland, MA) using an LSM880 confocal (Zeiss).

Cryosectioning and quantitative embryo measurements {#s4-10}
---------------------------------------------------

For cryosectioning, embryos were incubated in a 30% sucrose solution until they sank to the bottom of the vial. Embryos were then transferred to optimal cutting temperature compound (Tissue-Tek**[®]{.ul}** OCT, Sakura Finetek, Torrance, CA) overnight. The following day, embryos were transferred to mounting molds (Fisher Scientific) containing OCT and appropriately oriented to give sagittal or transverse sections. Embryo-containing molds were carefully transferred to dry ice until frozen and then temporarily to −80°C until cryosectioning. Cryosections of 10 μm were cut using a Leica CM3050S and imaged using a confocal microscope as described above.

To quantify immunostaining within gastrulating mouse embryos, transverse cryosections were imaged by confocal microscopy. For quantification of the relative levels of SOX2 and NANOG within different regions of the Epi, the anterior and posterior regions were manually selected using ImageJ software and immunostaining fluorescence levels in arbitrary units. Five cryosections were quantified per embryo and the levels normalized to the fluorescence levels of the Hoechst nuclear stain. At E6.5, three embryos were quantified, while as E7.5, two embryos were quantified. For quantification of the levels of pSMAD1/5/8 within different cell types within the gastrulating mouse embryo, transverse cryosections through the PS of E6.5 embryos were selected. Individual cells within the Epi, PS and mesodermal wings were manually selected using ImageJ software and fluorescence levels in arbitrary units. Data was normalized to the fluorescence level of the Hoechst nuclear stain. The PS was defined as BRACHYURY-expressing cells within the posterior Epi while the mesodermal wings were identified as cells that had left the Epi epithelial layer and were migrating between the Epi and VE. Three cryosections were quantified per embryo and three embryos were analyzed.

The diameter of embryos at different developmental stages was measured on acquired images using ImageJ software. Measurements were made along the anterior-posterior axis of transverse cryosections of embryos. Multiple cryosections at the widest region of the embryo were utilized and multiple embryos per developmental stage.
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###### Summary of expression data for a panel of factors used for cell fate assignments in this study.

Where data was not generated in this study, appropriate literature references are provided -- listed in bold lowercase letters, full references provided below the table. Where primary data is included in this study, the reference is given in the following format -- (Main text figure (Fig.\_) -- figure supplement (S\_): [Supplementary file 2](#supp2){ref-type="supplementary-material"}). Cell fates are color-coded as in [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"} and in table legend. At each gastrulation stage, each cell type was classified as 1 = factor expressed, 0.5 = factor expressed heterogeneously or at low levels, 0 = not expressed (white), ?=expression unclear from immunostaining and exact localization is unclear/unknown from published literature. FOXF1 is expressed in the embryonic mesoderm and also reported to be expressed within the PS at E7.0-E7.5 but PS expression is unclear. *Gsc* and *Hhex* are both expressed in the AxM although their expression has been reported to be transient in some studies and the exact timing of expression is not clear. To note, some cells of the PS coexpressed BRACHYURY, SOX2 and NANOG, likely a transition state between Epi and PS before SOX2 and NANOG are downregulated. It was unclear whether GATA6 was absent or expressed only at low levels in the ACD and early AOM. Certain markers were expressed in some but not all embryos at a particular stage -- likely indicating the onset of expression, for example SOX17 within the ExM at E7.0-E7.5. **\*\*\*** At E7.0-E7.5 both DE and mesoderm cells arise from the anterior PS and are spatially intermixed hence it is difficult to identify DE cells based only on localization. At this time DE therefore refers to presumptive DE cells arising from the anterior PS based on known marker expression.

10.7554/eLife.32839.024

###### Representative data of immunostained gastrulating mouse embryos utilized to identify marker signatures of distinct cell states.

Supplemental file comprising representative images of embryo data used in this study to identify in vivo marker signatures for particular cell states. Embryos were collected at different stages of development throughout gastrulation, from embryonic day (E) 6.25-E8.5 and immunostained for trios of marker combinations. File contains images of wholemount embryos and cryosections acquired by confocal microscopy. The expression patterns of the markers determined using this data are summarized in [Supplementary file 1](#supp1){ref-type="supplementary-material"}.

Major datasets {#s7}
--------------

The following previously published dataset was used:

Hayashi KKurimoto KOhta HSaitou M2011Reconstitution of the mouse germ-cell specification pathway in culture by pluripotent stem cells<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE30056>Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE30056)
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Reviewing Editor
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Australia

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Micropattern differentiation of mouse pluripotent stem cells recapitulates embryo regionalized fates and patterning\" for consideration by *eLife*. Your article has been favorably evaluated by Fiona Watt (Senior Editor) and three reviewers, one of whom is a member of our Board of Reviewing Editors. The following individuals involved in review of your submission have agreed to reveal their identity: Ronald McKay (Reviewer \#2); Valerie Wilson (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

In this study Morgani et al. describe a micropatterned mouse pluripotent stem cell culture system that models many aspects of early post-implantation embryo development. Beginning with Epiblast like cells (EpiLC), which approximate the stage of formative pluripotency, the authors show that the system can recapitulate primitive streak formation, as well as anterior mesendoderm and definitive endoderm patterning, based on expression of combinations of cell type specific markers within the cultures. The authors validate the system by showing that treatment with appropriate morphogens can bias in vitro patterning in a fashion consistent with the actions of BMP, WNT, FGF and ACTIVIN signaling in the embryo.

Essential revisions:

All three reviewers are enthusiastic about the value of this experimental system and agree that these findings will be of interest to the field. Reviewer 2 raises some questions concerning the interpretation of the data on EpiSC that should be addressed, as does reviewer 3. Please comment on these points.

\"When grown on a specific substrate the EpiLCs generated a series of intermediate states found in the embryonic and extra-embryonic posterior regions of the gastrulating mouse embryo. ES and EpiSCs do not show the same the same responses to the growth conditions used here. This difference is interpreted as suggesting the EpiLC is the common pluripotent state shared by mouse and human embryos. While this manuscript reports important data, is it not possible that the in vitro conditions used here do not adequately support all the cell fates adopted by either mouse EpiSCs or human induced pluripotent stem (iPS) cells?

More specifically, the formation of anterior neural fates was not extensively explored in this analysis. The conclusion of this study that EpiLCs are biased towards posterior embryonic and extra-embryonic mesodermal fates suggests that EpiSCs may be biased towards more anterior fates. This raises the possibility that EpiSCs may express functions normally found in the anterior extra-embryonic visceral endoderm. This possibility was not definitively excluded by the analysis presented here that is based on a restricted number of antibodies and did not employ genome wide analytical tools limiting the number of cellular states that might be detected. \"

\"One of the conclusions is that EpiSCs are \'functionally restricted in developmental potential\' (Results). However, EpiSCs can differentiate to a lot of cell types (see Huang et al., 2012): is there an argument that this micropattern culture has not fully revealed the spectrum of EpiSC differentiation?\"

Reviewer 2 requests some clarification regarding the unique outcomes of micropatterned cultures described here compared to other previous results.

\"Results: \'Micropatterned cultures do not contain extraembryonic cell types (namely primitive endoderm or trophectoderm derivatives), they instead formed radially symmetric cell fate\'. However, other 3d culture systems (e.g. van den Brink et al., 2014) generate asymmetry without extraembryonic cell types. Can the authors comment on how these differences could arise?\"

All reviewers note some concerns about the identification of specific cell types. Reviewers 1 and 2 suggest that citation of current literature might help support the identification of particular cell types. Reviewer 3 raises a number of specific queries concerning particular markers; like reviewer 2 this individual is concerned to know whether particular markers were assessed at specific stages. It might be helpful to present the information on the markers in a somewhat more organized form. Figure S8 could be revised (for some reason I could not find the legend to this figure) to indicate which markers were tested at what stage, to indicate what figures show expression in the micropatterned cultures as well as the embryos, to include callouts to those data which are not identified with a particular figure in the manuscript, to show what the levels in the heatmap mean, and to include references from the literature where applicable. Excel might be the appropriate format for presenting this information.

\"Since there was no attempt to characterise the cultured cells further, either through molecular techniques (e.g. single cell gene expression analysis using QRT-PCR or RNA-seq) or through studies of their further differentiation into appropriate lineages, the validation of these markers is particularly important. It is not easy to assess the fidelity with which the in vitro system replicates cells in the embryo on this basis of a few markers; it is possible that global examination of gene expression patterns might not support the identification of cell types, or that the cells in vitro might not have the developmental potential implied by the labels the authors assign to them. These limitations are shared by almost all studies of in vitro patterning to date, and at some stage, the field will have to progress beyond this level. At least, the basis for claiming that 2 or 3 markers can uniquely identify the cell types of interest (as tabulated in Supplemental [Figures 3F](#fig3){ref-type="fig"} and [8B](#fig8){ref-type="fig"}) should be clearly specified: is it the immunostaining in the manuscript, or can the unique identifiers be further supported by gene expression data from the literature. Supplementary [Figure 8B](#fig8){ref-type="fig"} is quite critical, linking the data to assignment of cellular identities. Perhaps the supplemental material could group together the embryo images with staining identifying particular cell types through various stages. I found it awkward to keep flipping back and forth to check this information.\"

See also these specific comments on markers for cell identification:

*Reviewer 1:*

1\) Subsection "EpiLCs recapitulate differentiation and spatial organization of posterior cell fates". [Figure 2A](#fig2){ref-type="fig"} what are the *Sox2* positive cells in the extraembryonic region?

2\) [Figure 2F](#fig2){ref-type="fig"}. What staining is shown in the top two panels of [Figure 2F](#fig2){ref-type="fig"}?

3\) Subsection "EpiLCs recapitulate differentiation and spatial organization of posterior cell fates". [Figure 2F, G, H](#fig2){ref-type="fig"} -- what are the Cdx2 positive cells and what is the basis for their identification?

4\) Subsection "EpiLCs recapitulate differentiation and spatial organization of posterior cell fates", fifth paragraph. [Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"} -- not clear that Otx2 is expressed in posterior epiblast from this image; indicate where is posterior.

5\) [Figure 3C](#fig3){ref-type="fig"} -- indicate in the legend what the little red dots do i.e. delineate region of interest.

6\) High resolution high magnification images of the embryos should perhaps be compiled somewhere to support the use of the markers in question.

*Reviewer 2:*

Along similar lines it would make the study more influential if the contemporary literature in early mouse development was more precisely cited. For example, the differences in the expression patterns of Nanog and Brachyury in the gastrulating mouse embryo that are central to the current report have been previously reported raising the important possibility that Nanog may have distinct functions in the inner cell mass and the primitive streak.

*Reviewer 3:*

1\) It would be good to re-check all the specifics in the rubric. Some queries that arose from using this as the overview to all the data, including:a) Was Nanog immunostaining done at all stages? It is listed as posterior epiblast throughout but I don\'t see the immunostains this refers to.

b\) Sox1-GFP should be added to the rubric to identify anterior epiblast.

c\) The rubric lists \'[Figure 5I](#fig5){ref-type="fig"}\' as a source of information -- I couldn\'t find panel 5I.

d\) Definitive endoderm at E7.5-8.0 should list [Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"} as a source.

e\) Was OTX2 stain done in E7.0-7.25 embryos?

2\) Some of the conclusions may need qualifying. For example check \'cells that coexpressed GATA6 and OTX2 ([Figure 3---figure supplement 1G](#fig3s1){ref-type="fig"}), corresponding to Mesoderm 1\': GATA6 and OTX2 are also expressed in endoderm. Is the argument that this is not endoderm because the endoderm only later expresses OTX2? Timings of individual markers may be a bit different in vitro. However, focusing on the most likely cell type is correct; just try and avoid overstating the certainty of a conclusion.

10.7554/eLife.32839.029

Author response

> Essential revisions:
>
> All three reviewers are enthusiastic about the value of this experimental system and agree that these findings will be of interest to the field. Reviewer 2 raises some questions concerning the interpretation of the data on EpiSC that should be addressed, as does reviewer 3. Please comment on these points.
>
> \"When grown on a specific substrate the EpiLCs generated a series of intermediate states found in the embryonic and extra-embryonic posterior regions of the gastrulating mouse embryo. ES and EpiSCs do not show the same the same responses to the growth conditions used here. This difference is interpreted as suggesting the EpiLC is the common pluripotent state shared by mouse and human embryos. While this manuscript reports important data, is it not possible that the in vitro conditions used here do not adequately support all the cell fates adopted by either mouse EpiSCs or human induced pluripotent stem (iPS) cells?

We thank the reviewer for this comment. It is true that the in vitro micropattern conditions may not fully recapitulate all of the factors contributing to cell fate specification and patterning in the embryo. Manipulation of the conditions utilized for micropattern differentiation may give further insight into this possibility and we have modified the Discussion to reflect this:

"The limited capacity of EpiSCs to pattern in isolation may stem from their elevated expression of signaling inhibitors \[Hayashi et al., 201110\]. \[...\] Further manipulation of the micropattern differentiation conditions may give novel insights into the unique requirements of these different pluripotent cell states ([Figure 1A](#fig1){ref-type="fig"}) for organized cell fate specification."

> \"One of the conclusions is that EpiSCs are \'functionally restricted in developmental potential\' (Results). However, EpiSCs can differentiate to a lot of cell types (see Huang et al., 2012): is there an argument that this micropattern culture has not fully revealed the spectrum of EpiSC differentiation?\"

We thank the reviewers for this comment. We agree that chimaera data has shown that EpiSCs are not inherently restricted in their developmental potential. We now removed that statement and clearly reference the chimaera data within the Discussion (ninth paragraph).

As discussed above, further protocol modifications might permit EpiSC differentiation towards a wider spectrum of cell fates as observed in vivo (see above comments). For example, as EpiSCs can be maintained in a variety of culture conditions \[1\] and, individual EpiSC lines display distinct functional biases \[2\], different EpiSC lines, EpiSC culture conditions or micropattern differentiation conditions could result in the specification of distinct cell fates. We believe that we have established the micropattern assay as a quantitative read out of cellular state, complementary to single cell or population assays since it focuses on cell communication and pattern formation, that could be used to address these questions. While it would be beneficial to investigate the effect of these variables on cell fate specification, it is beyond the current scope of this paper.

Furthermore, while EpiSCs did not exhibit obvious spatial patterning of cell fates when differentiated in isolation, it may be possible that they can efficiently pattern cell fates when mixed with other cell types on the micropatterns, such as EpiLCs, in a situation that more closely resembles in vivo chimaera assays.

> "More specifically, the formation of anterior neural fates was not extensively explored in this analysis. The conclusion of this study that EpiLCs are biased towards posterior embryonic and extra-embryonic mesodermal fates suggests that EpiSCs may be biased towards more anterior fates. This raises the possibility that EpiSCs may express functions normally found in the anterior extra-embryonic visceral endoderm. This possibility was not definitively excluded by the analysis presented here that is based on a restricted number of antibodies and did not employ genome wide analytical tools limiting the number of cellular states that might be detected. \"

The conclusion of the study is not that EpiLCs are biased towards posterior cell fates but that the conditions that they are exposed to (+BMP or --BMP) promote distinct cell fates. EpiLCs can form posterior cell fates in the presence of BMP and anterior PS cell fates in the absence of BMP. Conversely, the EpiSCs in this study form anterior cell fates in the presence or absence of BMP.

As EpiLCs and EpiSCs are derived from or represent the post-implantation embryonic epiblast, which does not give rise to extraembryonic trophectoderm or endoderm, it is unlikely that the micropattern system contains extraembryonic endoderm or trophectoderm cell types. We have added this to the text in order to clarify the reasoning:

"For the mouse micropattern differentiation we utilized pluripotent EpiLCs, corresponding to the Epi cells of the embryo, and thus the system likely lacked the neighboring extraembryonic cell types and the signals that they provide."

While we have carried out a thorough coexpression analysis of a panel of markers within individual cell populations present in the micropatterns and catalogued the cell populations that are present, the reviewers are correct that it is not possible to definitively assign an in vivo correlate to all cell populations present within the micropatterns. For example, it is problematic to distinguish between anterior primitive streak and axial mesoderm states that have a similar transcriptional signature. We will develop tools and protocols to facilitate the sorting of the cell populations identified in this current study for global transcriptional analysis and mapping to available embryonic data in future studies. We have now added a sentence to this affect:

"FOXA2/BRACHYURY-coexpressing cells observed in the absence of BMP ([Figure 7F, G](#fig7){ref-type="fig"}) may correspond to a subpopulation of anterior PS cells ([Figure 3A](#fig3){ref-type="fig"}) or alternatively AxM cells that have downregulated Gsc and Hhex. Global transcriptional analysis may be required to resolve these possibilities."

> Reviewer 2 requests some clarification regarding the unique outcomes of micropatterned cultures described here compared to other previous results.
>
> \"Results: \'Micropatterned cultures do not contain extraembryonic cell types (namely primitive endoderm or trophectoderm derivatives), they instead formed radially symmetric cell fate\'. However, other 3d culture systems (e.g. van den Brink et al., 2014) generate asymmetry without extraembryonic cell types. Can the authors comment on how these differences could arise?\"

We thank the reviewer for this comment. In vivo, the asymmetry of marker expression within the epiblast is initiated by signals from the extraembryonic trophectoderm and endoderm. It has previously been shown that, in the absence of these asymmetric extraembryonic signals, the epiblast no longer initiates asymmetric marker expression \[3-6\]. Although in vivo the source of asymmetry is the extraembryonic lineages, this does not mean that this is the only possible source of asymmetry in other contexts, for example in in vitro assays.

The reviewers draw attention to other studies where asymmetric marker expression has been demonstrated in vitro in the absence of extraembryonic cell types. However, those studies have fundamental differences in their methodology compared to the micropattern system. Pluripotent stem cell colonies differentiated on the disc-shaped micropatterns are confined in size and shape and begin as an epithelial monolayer exposed to a homogeneous medium. As such, there is no morphological or presumably signaling asymmetry. In contrast, the study by van den Brink et al. \[7\], referenced by the reviewers, involves three-dimensional embryoid body-like aggregates, assembled without size or morphological constraints and without constraints on growth/expansion during further differentiation. It is therefore likely that the aggregates are not morphologically symmetrical and, as a result, that individual cells may be exposed to distinct signaling environments and consequently initiate asymmetric signaling and marker expression.

In support of this hypothesis, when EpiLCs were differentiated on smaller diameter micropatterns, the width to height ratio of the colony was affected so that three-dimensional embryoid-body-like structures were formed. During the differentiation, these structures show morphological asymmetry that also correlated with a loss of marker radial symmetry. We have now added these results to the manuscript ([Figure 5](#fig5){ref-type="fig"}) and discuss this within the text:

"It should be noted that, on smaller diameter micropatterns, the width to height ratio of colonies was altered such that 80-140 μm diameter colonies generated taller, embryoid body-like aggregates. Over time, these three-dimensional structures exhibited morphological asymmetries ([Figure 5F](#fig5){ref-type="fig"}), which may explain the loss of radial symmetry in marker expression."

We have also now reworded the Discussion to further clarify this point:

"In vivo, localized signaling from the extraembryonic tissues, notably the anterior visceral endoderm (AVE), induces molecular asymmetries within the bilaterally symmetrical Epi leading to anterior-posterior axis establishment \[Stower and Srinivas, 2014\]. \[...\] However, as these structures are not geometrically uniform, the polarized marker expression likely stems from initial morphological asymmetries and there is still no evidence of spontaneous symmetry breaking within geometrically uniform structures."

> All reviewers note some concerns about the identification of specific cell types. Reviewers 1 and 2 suggest that citation of current literature might help support the identification of particular cell types. Reviewer 3 raises a number of specific queries concerning particular markers; like reviewer 2 this individual is concerned to know whether particular markers were assessed at specific stages. It might be helpful to present the information on the markers in a somewhat more organized form. Figure S8 could be revised (for some reason I could not find the legend to this figure) to indicate which markers were tested at what stage, to indicate what figures show expression in the micropatterned cultures as well as the embryos, to include callouts to those data which are not identified with a particular figure in the manuscript, to show what the levels in the heatmap mean, and to include references from the literature where applicable. Excel might be the appropriate format for presenting this information.
>
> \"Since there was no attempt to characterise the cultured cells further, either through molecular techniques (e.g. single cell gene expression analysis using QRT-PCR or RNA-seq) or through studies of their further differentiation into appropriate lineages, the validation of these markers is particularly important. It is not easy to assess the fidelity with which the in vitro system replicates cells in the embryo on this basis of a few markers; it is possible that global examination of gene expression patterns might not support the identification of cell types, or that the cells in vitro might not have the developmental potential implied by the labels the authors assign to them. These limitations are shared by almost all studies of in vitro patterning to date, and at some stage, the field will have to progress beyond this level. At least, the basis for claiming that 2 or 3 markers can uniquely identify the cell types of interest (as tabulated in Supplemental [Figures 3F](#fig3){ref-type="fig"} and [8B](#fig8){ref-type="fig"}) should be clearly specified: is it the immunostaining in the manuscript, or can the unique identifiers be further supported by gene expression data from the literature. Supplementary [Figure 8B](#fig8){ref-type="fig"} is quite critical, linking the data to assignment of cellular identities. Perhaps the supplemental material could group together the embryo images with staining identifying particular cell types through various stages. I found it awkward to keep flipping back and forth to check this information.\"

To address the reviewers' concerns, we have supplied [Supplementary files 1](#supp1){ref-type="supplementary-material"} and [2](#supp2){ref-type="supplementary-material"} comprising all embryo data used in this study including wholemount confocal images, confocal optical sections and cryosections of the markers utilized. Where we had used reporter ESC lines within the micropatterns and did not have access to good antibodies (for example for *Hhex, Goosecoid* and *Sox1*) or not all gastrulation stages were analyzed for a particular marker, we have supplied literature references indicating published expression data for those stages.

Furthermore, we have replaced the previous supplementary [Figure 8](#fig8){ref-type="fig"} with an Excel file as suggested. All embryo data is summarized in [Supplementary file 1](#supp1){ref-type="supplementary-material"} indicating expression (1), low or heterogeneous expression (0.5) or no expression (0). Supplied figure references indicate where the data can be found in the manuscript, additional data file or literature. We hope that this comprehensive and logical organization of the data now provides all of the necessary information in an easily searchable format.

> See also these specific comments on markers for cell identification:
>
> Reviewer 1:
>
> 1\) Subsection "EpiLCs recapitulate differentiation and spatial organization of posterior cell fates". [Figure 2A](#fig2){ref-type="fig"} what are the Sox2 positive cells in the extraembryonic region?

The strong *SOX2* signal present within the extraembryonic region, as in [Figure 2A](#fig2){ref-type="fig"}, represents non-nuclear staining within the extraembryonic visceral endoderm. This has been noted in the figure legend for [Figure 2A](#fig2){ref-type="fig"}. Additionally, higher resolution cryosection images have now been provided in the [Supplementary file 2](#supp2){ref-type="supplementary-material"} and clear non-nuclear signal highlighted with a blue arrowhead. Similar non-nuclear background is observed in the extraembryonic visceral endoderm with other antibodies, including CDX2, OCT6 and BRACHYURY, and may represent an artifact related to the vacuolated structure of these cells \[8\]. However, as we are not analyzing extraembryonic endoderm or trophectoderm cell types, this does not affect cell fate assignments in this study.

> 2\) [Figure 2F](#fig2){ref-type="fig"}. What staining is shown in the top two panels of [Figure 2F](#fig2){ref-type="fig"}?

The top 2 panels of [Figure 2F](#fig2){ref-type="fig"} show a merge of the markers indicated below. As this may have been unclear, we have now added a sentence to this effect into the figure legend: "Upper 2 panels represent a merge of the markers shown below."

> 3\) Subsection "EpiLCs recapitulate differentiation and spatial organization of posterior cell fates". [Figure 2F, G, H](#fig2){ref-type="fig"} -- what are the Cdx2 positive cells and what is the basis for their identification?

CDX2 positive cells most likely represent extraembryonic mesoderm based on a process of elimination of other markers and cell types. This reasoning is in detail in the Results section (subsection "FGF/ACTIVIN/WNT/BMP triggers spatially organized posterior fate specification", fifth and sixth paragraphs).

> 4\) Subsection "EpiLCs recapitulate differentiation and spatial organization of posterior cell fates", fifth paragraph. [Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"} -- not clear that Otx2 is expressed in posterior epiblast from this image; indicate where is posterior.

OTX2 staining is reduced in the posterior Epi relative to the anterior Epi. However, we still observed a nuclear signal. Cryosections have now been supplied within [Supplementary file 2](#supp2){ref-type="supplementary-material"} to further clarify this. We have now also provided a number of references \[9-11\] that show evidence (RNA in situ, immunostaining and transcriptional analysis) for low OTX2 expression within the posterior epiblast including the recent spatial transcriptome analysis of E7.0 embryos from Peng et al. \[9\] and clear immunostaining showing cells that coexpress OTX2 and FOXA2 within the mid-distal posterior Epi \[10\]:

"In agreement with a recent spatial transcriptional analysis of gastrulating mouse embryos \[Peng et al., 2016\], our immunostaining data suggested that posterior Epi cells may also express low levels of OTX2 ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}). At E7.0-E7.5, a fraction of distal posterior Epi cells begin to express FOXA2 ([Figure 3A](#fig3){ref-type="fig"}) \[Burtscher and Lickert, 2009\], some of which also express OTX2 \[Peng et al., 2016; Engert et al., 2013\]."

> 5\) [Figure 3C](#fig3){ref-type="fig"} -- indicate in the legend what the little red dots do i.e. delineate region of interest.

The dashed lines indicate the region of interest and this has now been added to the figure legend for [Figure 3](#fig3){ref-type="fig"} as well as for [Figure 2B](#fig2){ref-type="fig"}.

> 6\) High resolution high magnification images of the embryos should perhaps be compiled somewhere to support the use of the markers in question.

We have now supplied all embryo data in [Supplementary files 1](#supp1){ref-type="supplementary-material"} and [2.](#supp2){ref-type="supplementary-material"} This contains cryosections that display marker expression at higher magnification.

> Reviewer 2:
>
> Along similar lines it would make the study more influential if the contemporary literature in early mouse development was more precisely cited. For example, the differences in the expression patterns of Nanog and Brachyury in the gastrulating mouse embryo that are central to the current report have been previously reported raising the important possibility that Nanog may have distinct functions in the inner cell mass and the primitive streak.

References for the expression pattern of each marker utilized in this study have now been added throughout the text. We have also included references to recent Geo-Seq data \[9\] where expression within certain domains has not been extensively characterized in the literature e.g. Otx2 expression within the posterior epiblast.

> Reviewer 3:
>
> 1\) It would be good to re-check all the specifics in the rubric. Some queries that arose from using this as the overview to all the data, including:a) Was Nanog immunostaining done at all stages? It is listed as posterior epiblast throughout but I don\'t see the immunostains this refers to.

NANOG staining was done at E6.5-6.75, E7.0-7.5 and E7.75-8.0. We have now added all of this data including cryosections to [Supplementary files 1](#supp1){ref-type="supplementary-material"} and [2](#supp2){ref-type="supplementary-material"} and the references to the location in the main figures and can be found within [Supplementary file 1](#supp1){ref-type="supplementary-material"}.

> b\) Sox1-GFP should be added to the rubric to identify anterior epiblast.

This has now been added to [Supplementary file 1](#supp1){ref-type="supplementary-material"} with a reference to the expression pattern as described in the literature.

> c\) The rubric lists \'[Figure 5I](#fig5){ref-type="fig"}\' as a source of information -- I couldn\'t find panel 5I.
>
> d\) Definitive endoderm at E7.5-8.0 should list [Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"} as a source.

We thank the reviewer for bringing these errors to our attention and have now updated all information provided within [Supplementary file 1](#supp1){ref-type="supplementary-material"}.

> e\) Was OTX2 stain done in E7.0-7.25 embryos?

OTX2 immunostaining was carried out in E6.25, E7.5 ant E7.75 embryos but not E7.0-7.25 embryos. All data is shown in [Supplementary file 1](#supp1){ref-type="supplementary-material"} and literature references supplied for the missing E7.0-7.25 time point within the accompanying Excel file.

> 2\) Some of the conclusions may need qualifying. For example check \'cells that coexpressed GATA6 and OTX2 ([Figure 3---figure supplement 1G](#fig3s1){ref-type="fig"}), corresponding to Mesoderm 1\': GATA6 and OTX2 are also expressed in endoderm. Is the argument that this is not endoderm because the endoderm only later expresses OTX2? Timings of individual markers may be a bit different in vitro. However, focusing on the most likely cell type is correct; just try and avoid overstating the certainty of a conclusion.

To address this issue, we have reworded the text throughout to indicate that these are the most likely, rather than definitive, cell fate assignments based on marker combinations.

As the reviewer states, GATA6 and OTX2 are coexpressed in both mesoderm and in definitive endoderm (DE) cells. However, the GATA6-expression domain is devoid of the DE marker FOXA2 (found only in the center of micropatterns in the presence of BMP, [Figure 3E](#fig3){ref-type="fig"}). We also added a new figure panel to show that, furthermore, SOX17 (also a DE marker as well as being expressed in the extraembryonic mesoderm) is expressed in an almost entirely mutually exclusive fashion with GATA6 ([Figure 3---figure supplement 2A](#fig3s2){ref-type="fig"}). SOX17 and FOXA2 are also expressed within distinct colony domains (outer and central domains respectively, [Figure 3E](#fig3){ref-type="fig"}). Hence, while GATA6, OTX2, FOXA2 and SOX17 are all DE markers and are all expressed within the micropatterns, other than GATA6 and OTX2, their expression does not overlap. Based on these observations we had assigned GATA6/OTX2 cells as mesoderm rather than DE. We have modified the text to explain this reasoning in more detail:

"During the micropattern differentiation, multiple DE-associated markers were expressed, namely FOXA2, SOX17, GATA6 and OTX2. In vivo these markers are coexpressed within DE cells ([Figure 3---figure supplement 1E](#fig3s1){ref-type="fig"}) while in the micropattern differentiation FOXA2, SOX17 and GATA6 were expressed in a mostly mutually exclusive manner ([Figure 3---figure supplement 2A](#fig3s2){ref-type="fig"}), hence they marked separate non-DE populations."

We have also now added additional data to strengthen this assignment. We utilized a double reporter cell line for *Goosecoid* and *Hhex* \[12\], which are markers coexpressed within DE and axial mesoderm. In the presence of BMP, *Goosecoid* was not expressed. This confirms our initial observations, suggesting an absence of DE and axial mesoderm anterior cell fates. In the presence of BMP, we did observe *Hhex* expression although *Hhex* also marks haematopoetic cells arising in the allantois. This data has now been added within [Figure 3---figure supplement 2B](#fig3s2){ref-type="fig"} (see subsection "FGF/ACTIVIN/WNT/BMP triggers spatially organized posterior fate specification" seventh paragraph).

Alternatively, when we remove BMP, we observed coexpression of *Goosecoid* and *Hhex* indicating the presence of DE or axial mesoderm or both. We have also added this data to the manuscript ([Figure 7---figure supplement 1A-G](#fig7s1){ref-type="fig"}) (see subsection "The absence of BMP allows DE and AxM specification", second paragraph).
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